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Siddha system is said to be one among the Indian system of medicines, i.e., it 
is one in the AYUSH group.Siddhars are those who lived and maintained their body 
as they desired best. They were the devotees of Lord Siva and rejected everthing else 
in Tamil Saiva system which was inconsistent with pure theism. 
There are various principles present in Siddha system said by different 
Siddhars. The major and common concept of Siddha deals with Five Boodhas and 
Three Humours, respectively Prithivi, Appu, Theyu, Vaayu, Aagayam along with 
Vatham, Pitham and Kapham.  
“நிலந்த ீநீர்வளி விசும்ேபா ைடந்தும் 
கலந்த மயக்கம் உலகம் ஆதலின்”. 
- ெதால்காப்பியம் 
The physiology, pathology, diagnosis and treatment in siddha is based on the 
above said three humours. When these Humours in the human body get affected, it is 
said to be Dhosha or kutram. The fluctuations of these humours leads to disease, the 





- ேநாய் நாடல் ேநாய்முதல் நாடல் 2 
Our Siddhars, not only concentrated on the diagnosis and treatment, they have 
followed and given a various principles to lead a healthy and hygienic life. Siddha is 
built by vast number of Siddhars, such as Navanadha siddhar, padhinen siddhar, 
navakodi siddhar, nava siddhar. In this, padhinen siddhargal plays a major role in the 
Siddha system. 
Agathiyar is said to be the first siddhar in padhinen sidhargal. He have 
described that there are 4448 diseases in his book Agathiyar rathna churukka naadi. It 
includes 62 types of diseases and its classifications. According to this, Paandu noi is 
classified into 10 types.  
Paandu noi symptoms are more or less equivalent to Iron deficiency anaemia. 
Iron Deficiency Anaemia (IDA) is a very common disease prevalent in the society. 
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Long term oral iron therapy is commonly used as first line therapy but iron salts such 
as ferrous sulphate are associated with a high incidence of gastrointestinal side effects 
such as nausea, vomiting, diarrhoea or constipation. Because of their adverse effects, 
a safe, effective, cheap, and easily available drug is needed. Many drugs are available 
in Siddha system of medicine which have remarkable effects in treating anaemia. One 
such medicine is Karisalankanni chooranam is indicated for anaemia mentioned in 
Siddha classical literature. 
With the aim of that, this Poly Herbal preparation may be effective to manage 
childhood IDA without any synergistic effects. The present study was carried out to 
study the efficacy and safety of the Siddha poly herbal compound drug karisalankanni 





















AIM AND OBJECTIVE 
 
AIM: 
Paandu noi is an important haematological entity described in siddha 
literatures. It is essential to find out a simple drug to overcome this disease. The drug 
should be easily available, economic, easily, administered and also effective in 
smaller doses. Karisalankanni chooranam possess all the above characters. This is the 
reason for selecting this drug. 
 
OBJECTIVES 
1. To collect the literature of both siddha and modern aspects of the disease 
paandu noi. 
2. To have an idea about the prevalence of paandu noi with reference to age, sex, 
socio-economic status, poverty, seasonal variations etc. 
3. To know the aetiology, classification, symptoms, diagnostic methods and line of 
treatment compared with Iron deficiency anaemia. 
4. To know the alteration of the disease under the topics mukkutram, udal kattukal, 
poripulangal, envagai thervukal, neerkuri, neikuri. 
5. To make a clinical trial on patients with the trial medicine karisalankanni 
chooranam in the treatment of paandu noi. 
6. To make use of modern parameters in the investigation side to confirm the 
diagnosis and to follow the progress of the patients. 
7. To elicit bio-chemical analysis, toxicological analysis and pharmacological 
action of the trial medicine. 










REVIEW OF LITERATURE 
SIDDHA ASPECT 
ேவறுெபயர்: 
ெவண்ைமேநாய், ெவளுப்பு ேநாய், ெவண்பாண்டம். 
இயல்பு:  
இயற்ைக நிறமாறி, உடல் ெவளுத்து, கண்ைணயும் நகக் கண்ைணயும் 
நீக்கிப் பார்க்கின் குருதியின்றி ெவளுத்திருக்கும். 
- ேநாய் நாடல் ேநாய்முதல் நாடல் பகுதி 2 
ேதகத்தின் இரத்தத்தில் உள்ள சிவந்த அணுக்கள் குைறந்து ேதகம் 
ெவளுத்துவிடுவதற்குபாண்டுேநாய் என்று ெபயர். 




நம் நாட்டில் குழந்ைதகளிைடேய அதிக அளவில் கணப்படும் மிக 
முக்கிய ேநாய்களில் ஒன்று ெவளுப்பு ேநாய் ஆகும். 
இந்ேநாய் ஏைழ எளிய குடும்பங்களிலும் சுற்றுப்புறச் சுகாதாரத்ைத 
ேபனாத சுழ்நிைலயிலும் அதிகம் ஏற்படுகின்றது. 
அதிக அளவிலுள்ள இந்ேநாையக் கட்டுபடுத்த கருவுற்ற காலத்திேலேய 
தாய்க்கு ேபாதுமான இரும்புச் சத்துள்ளமருந்துகைள அரசு வழங்கி, 
குழந்ைதகளுக்கு இந்ேநாய் வராமல் தடுக்கிறது. இருப்பினும் பல்ேவறு 
காரணங்களால் இந்ேநாய் குழந்ைதகளுக்கு எளிதில் ஏற்படுகிறது. 
ெவளுப்பு ேநாய் குழந்ைதகள் பிறந்தது முதல் குழந்ைத பருவம் 
முழுவதும் ெதாடர வாய்ப்புண்டு. இந்ேநாய்க்கு சrயான முைறயில் சிகிச்ைச 
அளிக்காத நிைலயில், இதைன ெதாடர்ந்து ேசாைப, காமாைல, இதயேநாய்கள் 
ேபான்ற ேநாய்கள் உண்டாகும். 
ேநாய் ஏற்பட காரணங்கள்: 
 ெவளுப்பு ேநாய்க்கு மிக முக்கியக் காரணம் குழந்ைதப்பருவத்தில் 
ஏற்படும் ஊட்டச்சத்துக் குைறபாடு ஆகும். இரும்பு சத்துள்ள உணவு 
வைககைளத் தவிர்க்கும் நிைலயில் ேநாய் உண்டாகிறது. 
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 குருதியின் வலிைமையக் குைறக்க கூடிய உப்பு, புளிப்பு, துவர்ப்பு ஆகிய 
சுைவயுள்ள ெபாருட்கைள மிகுதியாக உண்ணும் ேபாது குடலில் இரும்புச் 
சத்துஉட்கிரகிக்கப் படுவது குைறகிறது. 
 கல், மண், சாம்பல்,திருநீறு, கற்பூரம் ேபான்ற உண்ணத்தகாத 
ெபாருள்கைள உண்ணல்(PICA). 
 குழந்ைத பருவத்தில் அதிகம் உண்டாகும் வாந்தி, கழிச்சல் ேநாய்களால் 
உடல் வன்ைம குைறந்து பாண்டு ேநாய் ஏற்படலாம். 
 “குடற்கிருமிகள்” ேநாய் அைனத்துக் குழந்ைதகளிடமும் காணப்படும் 
ெபாதுவான ஒரு ேநாய் ஆகும். இதில் ெகாக்கிப் புழுவின் (HOOK WORM) 
தாக்குதலால் ெவளுப்பு ேநாய் உண்டாகிறது. 
 குழந்ைதகளுக்கு ஏற்படும் ேநாய்களான கணம், அக்கரம், வலிப்பு, ேதாடம் 
ேபான்ற ேநாய்களுக்கு சrவர சிகிச்ைச அளிக்காத நிைலயில் ெவளுப்பு 
ேநாய் ஏற்படுகிறது. 
 பிறவி குைறபாடுகளின் காரணமாக குடலில் உள்ள குடல் உறிஞ்சிகளின் 
(INTESTINAL VILLI) சrயாக வளர்ச்சி அைடயாத நிைலயில் உட்ெகாள்ளும் 
உணவு உறிஞ்சப்படுவது குைறவதால் இந்ேநாய் ஏற்படலாம். 
 உடலின் உட்புறம் ஏற்படும் குருதிக் கசிவு (எ.கா.) நிணக்கழிச்சல், 
இைரப்ைபப் புண்.  
 இளம் குழந்ைதகளுக்கு நீண்ட காலம் பால் மட்டுேம பிரதான உணவாக 
வழங்கப்படும் நிைலயில் ஊட்டச்சத்து குைறபாட்டால் ெவளுப்பு ேநாய் 
உண்டாகிறது. 
 உடலில் அடிப்பட்டு குருதிக்கசிவு அதிகம் ஏற்பட்டால் அதைன ெதாடர்ந்து 
பாண்டு ேநாய் உண்டாகலாம். 
 நாட்பட்ட சுரம், ெதாற்று ேநாய்களால் ெவளுப்பு ேநாய் ஏற்படலாம். (எ.கா.) 
மேலrயா. 
 நச்சுத்தன்ைமயுள்ள மருந்துகைள அளவுக்கு அதிகமாக உட்ெகாள்ளும் 
நிைலயில் பாண்டு ேநாய் உண்டாகலாம். 
 நாட்பட்ட கல்lரல் வகீ்கம், மண்ணரீல் வகீ்கம் ேபான்றவற்ைற ெதாடர்ந்து 





ேநாய் வரும் வழி 
ெபாதுவாக வளர் இளம் குழந்ைதகள் குருதியின் வன்ைமையக் 
குைறக்கக் கூடிய உப்பு புளிப்புள்ள ெபாருட்கைள மிகுதியாகக் ெகாள்வதாலும், 
சுரம், ேபதி, வாந்தி, கீல்வாயு முதலிய ேநாய்களுக்குட்படுவதாலும், குருதிைய 
அளவு கடந்து ெவளியாக்கும் குருதியழல் ேநாய், குருதி கழிச்சல், முைளேநாய், 
குருதி வாந்தி முதலியைவ எற்படுவதாலும் ெவட்டுப்பட்டு மிகுதியாக குருதி 
ெவளிப்படுதலாலும் இந்ேநாய் உண்டாகும். அன்றியும் நச்சுத்தன்ைமயுைடய 
மருந்துகைள நாளளவுக்குமிஞ்சி உண்பதாலும், உடைல இைளக்கச் ெசய்யும் 
வயிற்றுபுழுேநாய், இைளப்புேநாய், நிணக்கழிச்சல் முதலியைவகளாலும் 
குருதிெபருக்ைகக் ெகடுக்கக்கூடிய ஈரல்ேநாய்களாலும், புைகயிைல, 
ெவற்றிைலப்பாக்கு, மண், சாம்பல், திருநீறு, கற்பூரம் முதலியைவகைள 
அடிக்கடி ெகாள்வதாலும் பாண்டுேநாய் வரும். 
- ேநாய் நாடி ேநாய்முதல் நாடல் பகுதி2 
 
“பிறந்தநாள் பிள்ைளக்குத் தாேன நன்றாய் 
பிதாவாேல பிணியுடலின் ேமேல ேதான்றும்” 
 
“விைனயது வருகுேநர்ைம விபரமா யுைரக்கேகளாய் 
அைனயது வாகந்தானு மபானனாம் வாயுகூடி  
புைனயது கிழ்மூலத்திற் புக்கினால் தடிக்கும் ேதகம் 
கனலதுெமத்தக்காணும் கண்ணது ெவளுக்குந்தாேன”. 
- பாலவாகடம் 
 
 “கருதிய மீனின் முள்ளும் கலந்துமி ெநய்யில் வாலும் 
  மருவிய எலும்புங் கல்லும் மங்ைகயர் மருந்தடீும் 
 பழகிய பழஞ்ேசாற்றாலும் பழமல நிைறைகயாலும் 
  மருகிய மயிர்களாலும் வந்திடும் ேநாயதாேம 
 புறவைர யுண்ைகயாலும் ேபாக நீருண்ைகயாலும் 
  சுரளேவ முடக்கிக் ெகாண்டு முறக்கிடக்ைகயாலும் 
 ெபருக ெவண்ெடாழியினாலும் பிறக்கேநாெயன்ேற காேண” 
- ேதைரயர் வாகடம்  
7 
 
ேதைரயர் வாகடத்தின் கூற்றுப்படி மீன் முள்ளினாலும், முடி, என்பு, கள், 
பைழயேசாறு, மாசுபடிந்த குடிநீர், தவறான முைறயில் உறக்கம் ெகாள்வதாலும் 
பாண்டுேநாய் உண்டாகிறது. 
 
 “திருந்திடும் பாண்டுேராகங் ேசர்ந்திடுங் குணத்ைத ேகளாய் 
  இருத்திடும் வாத பித்தச் சிேலற்பன மிைவதான் மாறும் 
 பrந்துதா ெனான்ேறாெடான்று ெபாருந்துவதாலு மண்ேணாடு 
  அருந்துவதாலும் பாண்டு அைணந்திடு ெமன்னலாேம 
 ஆகிய மூலந்தன்னி லைணந்த வுட்டணத்தினாலுந் 
  ெதாைகயர் ேமகந்தாரும் துயர்மிகு ேசர்தலாலும் 
 ேதகேபாசைனயுள்ளார்க்குத் தrத்திரஞ் ேசர்தலாலும் 
  ேவகமாந்திrேதாருங்கள் மிஞ்சிேய பாண்டுவாேம” 
- தன்வந்திr ைவத்தியம் 
தன்வந்திr ைவத்தியம் கூற்றுப்படி முக்குற்றங்களின் மாறுபாட்டாலும் 
மண் முதலியைவகைள உண்பதாலும் பாண்டு ேநாய் உண்டாகின்றது. 
 
 “ெசால்லாத கடிவிஷங்கள் குன்மம் பாண்டு 
  துயர்தரீாக் கன்மவிைன ெசய்த பாவம் 
 எல்ேலாரும் நைகக்க உடும்ெபடுத்த பாவி 
  இன்னமுண்டு விபரமாய் உலகிற் ேகேள.” 
- அகத்தியர் பrபூரணம் 400 
அகத்தியர் பrபூரணம் 400 கூற்றுப்படி பாண்டு கன்மவிைனயாலும் 
உண்டாகின்றது. 
பரதந்திர காரணங்களினால் பாண்டு உண்டாகும் என சரேபந்திர 
ைவத்திய முைறகள் பாண்டு காமாைல சிகிச்ைச நூல் கூறியுள்ளது. 
 “வயல்தனிேல பூநாக மண்ைணத் தாேன 
 வருந்தியது ெபாத்து ேபால வத்ைதயாகும் 






குருநாடி கூற்றுப்படி கிருமியால் பாண்டு ேநாய் உண்டாகிறது. 
 “குறிஞ்சிவரு நிலத்திற் ெகாற்ற முண்டி ரத்தம் 
 உறிஞ்சிவரு சுரமுண்டாம் அறிஞருைரக் 
 ைகயேம தங்குதரத் தாைம வல்ைலயுங் கதிக்கும் 
 ஐயேம தங்கும் அறி”. 
- பதார்த்த குண் சிந்தாமணி 
 
குறிஞ்சி நிலத்தில் வசிப்பவருக்கு பாண்டு ேநாய் உண்டாகும் என 
பதார்த்தகுண சிந்தாமணி கூறுகிறது. 
ேநாய் முற்குறிகள்: 
 சிறிது தூரம் நடந்தாலும் மூச்சுவாங்குதல் 
 உணவில் விருப்பமின்ைம 
 வாய் குமட்டல் 
 தைலசுற்றல் 
 கண் இருளல் 
 மார்பு துடித்தல் 
 உடல் இைளத்தல் 
உடலில் பித்தக்குற்றம் அதிகrத்து குருதியின் நிறத்ைதயும் எைடையயும் 
ெகடுத்து உடலுக்கு ேவண்டிய ஊட்டச்சத்திைன அளிக்காமல் உடைல ெவளுக்க 
ெசய்யும் ேபாது ேமற்கண்ட ேநாய் முற்குறிகள் உண்டாகின்றன. 
 
ேநாய் ெபாது குறிகுணங்கள்: 
இந்ேநாயில் உடல் வன்ைம நாளுக்கு நாள் குைறந்து நடக்க இயலாைம, 
தைலேநாதல், மயக்கமுண்டாதல், மூச்சுத்தடுமாறல், பசித்தகீ்ெகடல், உணவு 
ேவண்டாைம, உண்ட சிறு உணவும் வாந்தியாதல் ஆகிய குறிகள் ேதான்றும். 
இன்னும் மிகவும் ெவளுத்துத் ேதால் சுருங்கல், உடல் ெமலிந்து பளபளத்து 
ெவளுப்பாதல், நகக் கணுக்கள் தடித்து ெவளுத்தல், நாெவடித்து புண்ணாதல் 
அல்லது நாவின் ேமல்ேதாைலச் சவீிெயடுத்தது ேபான்று சிவந்து காணுதல் 
ெதாண்ைடக் கட்டல் என்னும் குறிகளும் காணும். 




“ெசடமது பித்த நீரால் ெதளித்ததால் ேதக ெமங்கும் 
கடமது கனக்க வூதிக் கண்ணுேம ெவளுக்குந் தாேன 
ெவளுத்திடு மிரண்டானால் விைனயழ சூழக் ேகளாய் 
கைளத்திடு சடலந் தன்னில் கனலதாய் வறட்சி காணும் 
பழுத்திடுந் ேதக மூதிப் பாண்டு ேபாலாம்”. 
- பாலவாகடம் 
பாலவாகடத்தின் கூற்றுப்படி கண் ெவள்விழி ெவளுத்தல், உடல் வறட்சி, 
உடல் ேசார்வு, வகீ்கம் உண்டாகும். 
“உற்றேதார் அன்னேபதம் அேராசகம் முதரமந்தம் 
      முற்றிமார்பு ேநாய் மூத்திரம் ெபான்னின் வன்ைம 
ெவள்ளிேசர் புறங்கால் ைகவகீ்கமுடல் ெவளுத்தல் 
      ேவர்த்தல்பற்றி ெதாக்கிற்காய் பணித்திய பாண்டுவாேம” 
- அகத்தியர் ைவத்தியரத்தினச்சுருக்கம் 
அகத்தியர் ைவத்தியர் ரத்தினச் சுருக்கக் கூற்றுப்படி பசியின்ைம, 
மார்புவலி, சிறுநீர் நிறம் மாற்றம், காணுக்கால் வகீ்கம், கண் இைரப்ைப 
வஙீ்கல், உடல் ெவளுத்தல் உண்டாகும். 
 
சரும ெவடிப்பு, அடிக்கடி காறி உமிழ்தல், ேதகம் ெமலிதல், மண் 
சாப்பிடுவதில் விருப்பம், கண்கைளச் சுற்றிலும் வகீ்கம், மலம் மூத்திரம் 
முதலியைவகள் மஞ்சள் நிறமைடதல், சாப்பாடு நன்றாக ெசrயாைம முதலான் 
குறிகள் ஏற்படும். 
- சரேபந்திரர் ைவத்திய முைறகள் 
 
 “உண்டாகும் ேவைளதன்னில் ேதகேநர்ைம 
  உறுதியாய்ச் ெசால்லுகிேறன் நன்றாய் பாரு 
 குண்டான முகம் கண்கள் உதடு நாக்கு 
   குறிப்பான வாய் ேவகும் ேதக முற்றும் 
 ேவண்டாக ேவயுலர்ந்து ெவண்ைமயாகி 
   விரல் நகங்கள் முழுவதிலும் ரத்தம் வற்றி 
 கண்டான கால்கள் தான் தணிந்து நிற்கும் 
   கருவான நாடியது ெமதுவாய்ப் ேபாேம 
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 ேபாேமதான் தபீனங்கள் மட்டுப்பட்டு 
  ெபாலிவான கண்விழிகள் ெபருத்துத் ேதான்றும் 
 ஆெமதான் அசதியு மாயாசங் கண்டு 
  அவர் நைடயும் தள்ர்ந்து ெபருமூச்சுக் கண்டு 
 மூேமதான் மூர்ச்ைசயுடன் மார்துடித்து 
  முடிவான கணுக்காலில் வகீ்கமுண்டாய் 
 தூேம தானிருதயத்தின் வதனந் தன்னிற் 
  துருத்தி நிகர் சத்தமது ேகட்கும்பாேர”. 
- அகத்தியர் குணவாகடம் 
 
அகத்தியர் குணவாகடத்தின் கூற்றுப்படி ேதால் வறட்சி, முகம் கண், 
நாக்கு நகக்கண் ெவளுத்தல், உடல்ேசார்வு, நாடிநைட குைறவு, பசியின்ைம, 
கண்இைரப்ைப வஙீ்கல், மார்பு படபடப்பு, மூட்டு வஙீ்கல் உண்டாகும். 
 
பாண்டு ேநாயின் வைககள்:  
சித்த மருத்துவ நூல்களின் அடிப்பைடயில் பாண்டு ேநாயின் வைககள் 
பலவாறாக வைகப்படுத்தப்படுகிறது. 












 ஊது பாண்டு 




 வாதப் பாண்டு 
 பித்தப் பாண்டு 
 சிேலற்பன பாண்டு 
 இரத்தப் பாண்டு 
 அசாத்தியப் பாண்டு 
ஜவீ ரக்சாமிருதம் 
 வாதப் பாண்டு 
 பித்தப் பாண்டு 
 கபப் பாண்டு 
 திrேதாஷப் பாண்டு 
 மிருதிகாப்புக்தப் பாண்டு 
ேராக நிர்ணய சாரம் 
 வாதப் பாண்டு 
 பித்தப்பாண்டு 
 கபப் பாண்டு 
 முக்குற்றப் பாண்டு 
 விடப் பாண்டு 
ைவத்திய சார சங்கிரகம் 
 வாதப்பாண்டு 
 பித்தப்பாண்டு 
 மூலப் பாண்டு 
 மூலபித்தப் பாண்டு 




 கபப் பாண்டு 
 முக்குற்றப் பாண்டு 







 கபப் பாண்டு 
 முக்குற்றப் பாண்டு 
 பித்தவாதப் பாண்டு 
 சன்னிவாதப் பாண்டு 




 கபப் பாண்டு  
 சன்னிப் பாண்டு 
 மிருதிகாப்புக்தப் பாண்டு 
அனுேபாக ைவத்திய ேதவ ரகசியம் 
 வாதப்பாண்டு 
 பித்தப்பாண்டு 
 கபப் பாண்டு 
 முக்குற்றப் பாண்டு 
 விடப் பாண்டு 




 சிேலத்துமப் பாண்டு 
 திrேதாஷப் பாண்டு 
 விஷப் பாண்டு 
சரேபந்திர ைவத்திய முைறகள் பாண்டு காமாைல சிகிச்ைச 
 வாதப்பாண்டு 
 பித்தப்பாண்டு 
 கபப் பாண்டு 
 சந்நிபாதப் பாண்டுேராகம் 




பாண்டு ேநாயின் குறிகுணங்கள்: 
 சிதம்பர தானுப்பிள்ைள அவர்களால் இயற்றப்பட்ட நூலில் 
குழந்ைதகளில் உண்டாகும் பாண்டு ேராகம் மிகச்சிறப்பாக 
எடுத்தியம்பப்படுகிறது. அதன் விவரம் வருமாறு, 
 
வாதப் பாண்டு 
 “ெவளுத்துப்ேபாம் வாதெமனும் பாண்டுதானும் 
  ெவளிறியங்கம் ெபாள்ளலுண்டாய் தமரு வழீும்  
 கழுத்தின் கீழ் ேதய்ந்து கக்கலிருமல் காட்டும் 
  கண் ெவளுத்து கறுப்பாக ரத்தம் வழீும் 
 பழுத்த பழம்ேபால் பதுங்கும் உதரம்கண்டாய் 
  பார்த்திடுகில் பளபளெவன மின்னிக் கானும் 
 ெசபுத்திடும் ேசாைலகுயில் மயிேல ேகளாய் 
  ேசதங்கள் வாராது திறமாய்ச் ெசய்ேய”. 
 உடல் ெவளுத்தல், கண் கருநிறமைடதல், ேதால் பளபளப்பைடதல் ஆகிய 
குறிகுணங்கள் வாதப் பாண்டு ேநாயில் காணப்படும். 
 
பித்தப் பாண்டு 
 “ெதாப்புளும் வயிரும் தள்ளி குடல்தன்னில் ஊற்ற முண்டாய் 
  தப்பிைள ேபால் திரண்டு சrரமும் ெவளுப்ேப ேயறும் 
  ைமப்புறும் குழலினாேல வாயுலர்ந்திருக்கும் கண்டாய் 
  இப்படி குணங்கள் கண்டால் பித்தபசைள பாண்ேட”. 
பித்தப் பாண்டுவில் வயிறு ஊதல், ெகாப்புள் வகீ்கம், குடல் வகீ்கம், 
ேதால் வறட்சி காணும். 
 
சிேலற்பனப் பாண்டு 
 “புக்கிடும் ேசற்பபாண்டு ெபாருந்திய குணேம தன்னில் 
  கக்கிடும் ெரத்தம் ேபாேல கண்ெவளுப்பாகும் ேமனி 
 சிக்கிடும் சிறுநீர் ேபதி சிறுகேவ ெகண்ைடப் பற்றி 
  ேபாக்கிடும் ெதாப்புள்சுற்றி ெபாருந்திய சுடைலேசரும்”. 
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 சிேலற்பனப் பாண்டு ேநாயில் குருதிவாந்தி, கண் ெவள்விழி மற்றும் 




          “சாருேம ெரத்த பாண்டு சrரத்ைத சுருக்கி ேமலும் 
  ஊருேம அங்கெமல்லாம் உணர்ந்திடும் உதரம் விம்மும் 
          காறுேம மூக்கில் ெரத்தம் கண்மஞ்சள் நிறேம 
  ஆருேமா அறிந்திடாமல் அய்ேயழில் மரணமாேம”. 
 ரக்தப் பாண்டு ேநாயில் உடல்  எைட குைறதல், அrப்பு, குருதிவாந்தி, 
கண் மஞ்சள் நிறமாக மாறி 5-7 நாட்களில் மரண்ம் ஏற்படும். 
மண்ணுண் ெவளுப்பு ேநாய் 
சிறு குழந்ைதகளும் சிறு வயதின்ரும் மண் சாம்பல் ெசங்கல் திருநீறு 
கற்பூரம் இவற்றின் மீது தனித்த இச்ைசக் ெகாண்டு அளவு கடந்து உண்பதால் 
காணும் ேநாயகும். உட்ெகாண்ட ெபாருளுக்கு ஏற்ப வயிறு ஊதல், ெசrயாைம, 
வாந்தி, கழிச்சல், சுரம், வயிற்றுப்புழு முதலிய ேநாய்கள் கண்டு ெமலிந்து குருதி 
வற்றி ெவளுத்து வஙீ்கி மார்பு துடித்தல் முதலிய குறிகுணங்கைளக் காட்டும். 
அசாத்திய பாண்டு 
“ஆற்ேம அசாத்தியபாண்டு அங்கமும் ெவளுப்பதாகி 
 சறீுேம ெதாண்ைடக்குள்ேள சில்லிட்டைடத்தாப் ேபாேல 
நாறுேம ேதகெமங்கும் நடுக்கிடும் உதரம் வற்றி 
 பாறுேம பதிேனழாம் நாள் பகர்ந்த நல்லிைளப் புண்டாேம 
 
இைளத்திடும் காறுபூறாய் இருமலும் மூச்சும் முட்டி 
 கைளத்திடும் ைகயும் காலும் கண்ணது மூடிக் ெகாள்ளும் 
தைளத்திடும் பால்ர்க்கும் சதியது வாராெதன்று 
 விைளத்திடும் மயிேல ேகளாய்”. 
அசாத்திய பாண்டு ேநாயில் உடல் ெவளுப்பு, ெதாண்ைடக் குளிரல், உடல் 





முன்பு ேநாய் வரும் வழியில் கூறியவாறு உடல் வன்ைம குைறந்து 
பசதீ்த ீ ேகடைடந்து உண்ட உணவு சrயாகச் ெசrயாமற் ேபாகும். உணவு 
ேகட்டால் இரச குருதிகளுக்கு ஊட்டம் ெபறாது. ேதாலுக்கு நிறத்ைதக் 
ெகாடுக்கும்அழல் ெமலிந்து நிறத்திலும் எைடயிலும் குைறந்து தகீ்குற்றத்ைதப் 
ெபருக்கும். அதனளவாக மற்ைறய குற்றங்களும் தன்னிைலயில் திrந்து 
பரவுகாலின் வன்ைமையக் ெகடுத்து ேநாைய உண்டாக்கும். ெநாயின் வன்ைம 









 மூச்சுவிடல் வாங்கல் 
 மனெமாழி ெமய்களுக்குச் ெசயைலத்தரல் 
 மலம் முதலிய பதினாங்கு விைரவுகைள ெவளிப்படுத்தல் 
 சாரம் முதலிய ஏழு உடற்கட்டுகும் ஒத்த நிகழ்ச்சிையத் தரல் 
 ஐம்ெபாறிகட்கும் வன்ைமையக் ெகாடுத்தல் 
வைககள்-10: 
1. பிராணன் 
பாண்டு ேநாயில் மூச்சுவிட சிரமம் , உணவு ெசrயாைம ஏற்படும். 
2. அபானன் 
பாண்டு ேநாயில் உணவின் சாரம் ேசரேவண்டிய இடங்களில் 
ேசர்ப்பிக்காது. கழிச்சல் மலக்கட்டு சிறுநீர் குைறவு உண்டாக்கும். 
3. வியானன் 
பாண்டு ேநாயில் உடல் வகீ்கம் கண் உதடு ெவளுத்தல் உண்டாகும். 
4. உதானன் 












பாண்டு ேநாயில் தூக்கமின்ைம உண்டாகும். 
10. தனஞ்ெசயன் 
பாண்டு ேநாயில் பாதிப்பைடயாது. 
 
பித்தம் 
பாண்டு ேநாய் வர முதல் காரணம் பித்தக் குற்றமாகும். 
பித்தம் வாழுமிடம் 
பிங்கைல, பிராணவாயு, நீர்ப்ைப, மூலாக்கினி, இருதயம், தைல, 
ெகாப்பூழ், உந்தி, இைரப்ைப, வியர்ைவ, நாவிலூறுகின்ற நீர், ெசந்நீர், சாரம், 
கண், ேதால். 
இயற்ைகப் பண்பு 
தன் இயற்ைக நிைலயில் நின்று ெசrப்பித்தல், ெவம்ைம, பார்ைவ,பசி, 
நீர்ெவட்ைக, சுைவ, ஒளி, நிைனப்பு, அறிவு, வன்ைம, ெமன்ைம என்பைவ 
உண்டாக்கி உடற்குத் துைண புrயும். 
பித்தத்தின் ெதாழில்கள் 
 உடலில் ெவப்பமுண்டாதல் 
 ெசந்நிற அல்லது மஞ்சள் நிறம் ேதான்றல் 
 உண்ட உணவுப் ெபாருட்கள் பக்குவைடயும் ேபாதும் ெசrக்கும் 
சமயத்திலும் ெவப்பமுண்டாதல் 
 வியர்த்தல் 
 மயக்கம் ஏற்படல் 
 ெசந்நீர் தன் அளவில் மிகுதல் அவ்வாறு மிகுந்த ெசந்நீர் ெவளிப்படுதல் 
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 ேதால் கண் மலம் சிறுநீர் முதலியன மஞ்சள் நிறமைடதல் 
 சறீ்றம் வணக்கமின்ைம அைசவின்ைம நிைனவு ெவறி ெமலிவு எrவு 
உண்டாதல் 
 எச்சுைவயும் ைகப்பாகேவனும் புளிப்பாகேவனும் காணுதல் ஆகியைவ 
அழலின் ெதாழில்களாகும். 
பித்தத்தின் வைககள் 
1. அனற் பித்தம் 
பாண்டு ேநாயில் பசியின்ைம உண்டாகும் 
2. இரஞ்சக பித்தம் 
பாண்டு ெநாயில் கண் ெவள்விழி ேதால் ெவளுத்திருக்கும் 
3. சாதக பித்தம் 
அன்றாட பணிகைள சrவர ெசய்ய இயலாமல் உடல்ேசார்வு 
உண்டாகும் 
4. ஆேலாசக பித்தம் 
இயல்பு 
5. பிராசக பித்தம் 
பாண்டு ேநாயில் கண் ெவள்விழி, ேதால் ெவளுத்திருக்கும். 
 
பாண்டு ேநாயில் எண்வைகத் ேதர்வு 
எண்வைகத் ேதர்வுகள் 
பிணிைய அறியும் வழி மருத்துவ நூல் வல்லுநர்களால் எண் வைகயாய் 
வகுக்கப்பட்டுள்ளது. 
 “நாடிப்பrசம் நாநிறம் ெமாழிவிழி 
 மலம் மூத்திரமிைவ மருத்துவராயுதம்” 
- ேநாய் நாடல் ேநாய்முதல் நாடல் 
என்பதனாலும் 
     “ெமய்க்குறி நிறந்ெதானி விழிநாவிருமலம் ைகக்குறி” 





 “ெகாண்டிடேவ கயேராகி காச ேராகி 
  குறிப்பாகச் சிற்றின்பம் ெசய்த ேபர்கள்  
 அண்டிடேவ தrத்திரர்கள் விருத்தர் பாலர் 
  அன்பாகத் தண்ணrீல் மூழ்கிேனார்கள் 
 ெகாண்டிடேவ இவர்களது உறுப்பின் தாது  
  கூறேவ முடியாது எவர்க்கும்க் கிட்டும் 
 பண்டிடேவ இப்பrட்ைச யார்தான் காண்பார் 
  பராபரத்தின் மகிைமயிது பாரு பாேர”. 
- ேநாய் நாடல் ேநாய் முதல் நாடல் 
பாலர்களுக்கு நாடி நைடயின் உண்ைம சrயாகப் புலனாகாவாம். எனேவ 
பாண்டு ேநாயினால் பாதிக்கப்பட்ட குழந்ைதகளின் நாடிநைட இயன்றவைரயில் 
ஆய்வாளரால் எடுத்துக் காட்டப்பட்டுள்ளது. 
 
பாண்டு ேநாயின் நாடிநைட 
பித்த நாடி: 
 “ஆேமதான் அத்திசுரம் பாண்டு ேசாைக 
  ஆழான விடாச்சுரமும் பிரேம கந்தான் 
 ேபாேமதான் காமாைல பித்த ெவட்ைட 
  ெபால்லாத பாண்டுடேன சிவந்த நீராம் 
 ேதகேமதான் சிவப்பாயு மஞ்ச ளாயுஞ் 
  சிறுசிறுத்து இருண்டுவருங் கழிவி ழுந்து 
 நாேமதான் ேசான்ேனாேம பித்தக் கூறு 





           “ேசத்தும நாடி யிளகினால் பாண்டாகும்”. 
           “கானமுள்ள ேசத்துமந்தான்னிளகில்……….. 




   “கண்டாேயா சிேலற் பனத்தில் வாதநாடி கலந்திடுகில் 
  ……………………………………………………………………..பாண்டு……” 
“உண்டாேயா ேசத்துமத்தில் வாதநாடி 
  கலந்திடுேமல் பாண்டு பிறக்குந்தாேன.” 
 
ஐயபித்த நாடி 
  “இடமான ேசத்துமத்திற் பித்தநாடி 
  எழுந்தணுகில் பாண்டாகும்.” 
 
2. ஸ்பrசம் 
 ேதால் வறட்சி, ெசாறெசாறப்பு காணும். 
 
3. நா 
பாண்டு ேநாயில் நாெவடித்துப் புண்ணாதல், நாவின் ேமல் ேதாைலச் 
சவீிெயடுத்தது ேபான்று சிவந்து காணும் அல்லது நாக்குப் பட்டுத்துணிேபால் 
வழுவழுத்து ெவளுத்தல், சுைவயின்ைம உண்டாகும். 
 
4. ந◌ிறம் 




 பாண்டு ேநாயில் கண் ெவள்விழி ெவளுத்திருக்கும். 
7. மலம் 
 மலக்கட்டு கழிச்சல் ஏற்படும். 
8. மூத்திரம் 





பாண்டு ேநாய் உற்பத்திையக் காட்டும் நீrன் எஞ்சிலக்கணம் 
 “இயற்ைக நீர் சுருங்கினும் இதுவும் சலப் ெபாருள் 
  ெசயற்ைக யாயிருந்தினும் சிறுத்து நீrதுவும் 
 பாண்டு ேநாய்ச் சம்பவத்ைதத் தருமிதில் 
  தூண்டுறாப் ேபதியும் ேசார்வும் பிறக்குேம.” 
- ேநாய்நாடல் ேநாய்முதனாடல் திரட்டு 
ஒரு காரணமுமின்றி இயற்ைக அளவுக்குக் குைறந்து இழியும் நீரும்; நீர்ப் 
ெபாருள்கைள மிகுதியாயுண்ணினும் குைறந்திழியும் நீரும்; பாண்டு ேநாய் 
உற்பத்திக்கு வழியாகும். இதனால் நீக்கக்கூடாத ேபதியும். 
ெநய்க்குறி 
“விைரவுடன் கதிர்ேபால் நீண்டு  
ேவற்றுைமக் குணங்கள் கண்டால் 
குருதிதான் ெகட்டு நாசம்  
குன்றிய குணம்ெதன்ேன.” 
- ேதைரயர் 
பாண்டு ேநாயில் ெநய்க்குறி கதிர் ேபால பரவும். 
பருவகாலங்கள் 
கார் காலம் மற்றும் கூதிர் காலம். இவ்விரு காலங்களில் பித்தம் 
தன்னிைல வளர்ச்சி மற்றும் ேவற்றுநிைல வளர்ச்சி அைடயும். 
நிலம் 
குறிஞ்சி ெநய்தல் மற்றும் பாைல நிலத்தில் வாழும் மக்களுக்கு பாண்டு 
ேநாய் வருவதற்கான வாய்ப்புகள் உள்ளன. 
பாண்டு தரீும் தரீாக் குறி 
  “அசாத்தியமாம் சிேலத்துமமும் ெதாந்தம் ெரத்தம் 
  அகலுேம வாதபித்தம் சாத்தியமாகும்.” 
- குழந்ைத ேநாய்கள்சிதம்பரதானுபிள்ைள 
க◌ுழந்ைதகளுக்கு உண்டாகும் ஐந்து வைக பாண்டு ேநாய்களில் வாதப் 
பாண்டு, பித்தப் பாண்டு இரண்டும் சாத்தியம். 





பாண்டு ேராகிக்கு வகீ்கம், ேசாம்பல், தாகம், அேராசகம், வாந்தி, விக்கல், 
இருமல், ேபதி என்னும் இக்குணங்கள் உண்டாகி எந்த ெபாருைளப் பார்த்தாலும் 
மஞ்சள் நிறமுண்டானால் அசாத்தியம். 
- அகத்தியர் ைவத்திய பிள்ைளத்தமிழ் 
 
கண்ணுசாமியம் 
“பாண்டு பிரேமகம் பன்வாத சூைல குன்மம் 
ேவண்டா சயஞ்சன்னி ெவண் ேசாைப- நீண்ட 
அதிநீேர காமாைல யானபிணி தம்மு 
ளதி சாரமா காதறி 
 
ெசால்லு பித்தத்திற் ேசாைப ேசாைபதனில் வாயுெதாந்தம் 
வல்லவதிற் பாண்டுவன் பாண்டில் – நல்ல 
வயிற்றுக் கடுப்பு வளர்கடுப்புற் சதீம் 
பயிலிற் ெகடுதி ெயனப்பன் 
   
ெவப்புப் பிணியதனில் ெவம்ேமகத்தால் வருந்தின் 
தப்பு மிைக நீேர தானிறங்கின்- ெசப்பும் 
கிராணியிற் பாண்டில் கிளர் நீர்சுருங்கிற் 
பிராணன் பிrயுெமனப் ேபசு.” 
 
சரேபந்திரர் ைவத்திய முைறகள் 
வகீ்கத்தில் மஞ்சள் நிறம் காணப்பட்டால் குணம் ஏற்படாது. 
மலச்சிக்கேலா அல்லது பச்ைச நிறமான அதிசாரேமா ஏற்பட்டால் அசாத்தியம். 
பலவனீம், வாந்தி, மூர்ச்ைச, அதிக நாளான பாண்டு ேராகம் சிகிச்ைசக்கு 
வசப்படாது. நாவறட்சி, இரத்தக் குைறவினால் உடல் ெவளுப்பு 
முதலியைவகலுடன் கூடிய ேராகியும் குணமைடவது சிரமம். 
பற்கள், நகம், கண் இைவகள் அதிகம் ெவளுத்தாலும் எல்லவற்ைறயும் 
ெவண்ணிறமாக பார்த்தாலும் அந்த ேராகம் அசாத்தியமாகும். அசாத்திய 
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ேராகத்ைத முற்றிலும் குணப்படுத்த முடியவிட்டாலும் சிறிது குறிகுணங்கைள 
குைறத்து ஆயுைளயும் சில காலம் நீடிக்கச் ெசய்யலாம். 
ைககள் கால்கள் தைல முதலான இடங்களில் வகீ்கம் ஏற்பட்டு இைளத்து 
ைககால்களும் இைளத்து வயிறு ெபருத்துமுள்ள் பாண்டு ேராகிையயும் 
ஆண்குறி, ெதாைடயிடுக்கு ஆகிய இடங்களில் வகீ்கம், அடிக்கடி மயக்கம், 




பாண்டுவின் அசாத்திய இலட்சணங்கள் 
1. நீடித்து ெதாடர்வதும் மிக்க முதிர்ந்து ேபானதுமான பாண்டு சிகிச்ைசக்கு 
வசப்படாது. 
2. அவயங்கள் வஙீ்கிப் ேபாய் எல்லாப் ெபாருளும் மஞ்சளாக ேதான்றினால் 
தரீாது. 
3. இறுகிய ெசாற்ப மலத்துடன் மஞ்சள் நீராகவும் கபத்துடன் கூடியதாகவும் 
அதிசாரம் உண்டானால் அசாத்தியம். 
4. அதிக ததீ்தன்ைம அைடந்து அவயங்கள் ெவண்ைமயாகி வாந்தி மூர்ச்ைச 
நாவறட்சி உண்டானால் அசாத்தியம். 
5. இரத்தம் ெகட்டு உடல் முற்றும் ெவளுத்தால் தரீாது. 
6. ேதகத்தின் ைக, கால், தைல வகீ்கம் உடல்வற்றி இைளத்துப் ேபானால் 
குதம், ஆண்குறி, பீஜம் வகீ்கம் இருந்தால் தரீாது. 
7. மிக்க இைளப்பு மயக்க நிைல காணப்பட்டால் தரீாது. 
8. அதிசாரம் சுரம் ெகாண்ட பாண்டு தரீாது. 
மருத்துவப் பrகாரம் 
பிணிக்கப்பட்ட வளி, அழல், ஐயம் என்னும் முக்குற்றத்ைதத் தன்னிைலப் 
படுத்துதல் மருத்துவம் என வழங்கப்படும். பிணிக்கப்பட்ட முக்குற்றங்கள் 
ஐம்புலங்கள், ஏழு உடற்தாதுக்கள் ஆகியைவகைள தன்னிைலப்படுத்தும் 
தன்ைமயுைடயைவ மருந்தாகும். 
மருந்து அகமருந்ெதன்றும் புறமருந்ெதன்றும் இருபிrவாகக் ெகாள்ளினும் 
முக்கியமாக தாவரப்ெபாருள், தாதுப்ெபாருள், சங்கமப் ெபாருள் என மூன்று 
வைகயாக வகுத்தனர். இதைன ேதரன் கூறிய பிரகாரம் 
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“கற்பங்க ளாதி கழறு மருந்து முைற 
விற்பனங் களாக விளங்குவதற்கு- முற்பங்கு 
மூலிக் கருப்ெபாருள் மூலப்ெபாருள் வைககள் 
ேவலிக்கு ேநரா குேம.” 
சித்த மருத்துவ முைறப்படி ேநாய்க்கு மட்டும் மருத்துவமின்றி அதைன 
வராது தடுக்கவும் காயகற்பமாகவும் மருந்துகள் பயன்படும் 
“உற்றா னளவும் பிணியளவுங் காலமுங் 
கற்றான் கருதிச் ெசயல்.” 
- திருக்குறள் 
ேநாயினன் அைடந்த குற்ற ேவறுபாடுகளின் மிகுதல் குைறதல் 
அளைவயும் அதனால் ேநாயுற்றான் ெபற்ற ேநாயின் கால அளைவ அறிந்து 
சிந்தித்து தகுந்த மருத்துவம் புrவது அவசியம். 
 
மருத்துவ வழிமுைற 
ேகடைடந்த முக்குற்றம் வாயுக்கள், இரத்தத்தாது இதைன சமப்படுத்தும் 
மருந்துகளாக இருக்க ேவண்டும். நாம் ெகாடுக்கும் மருந்துகளானது 
இரஞ்சகப்பித்தத்ைத சமப்படுத்தி இரத்தத்தாதுைவ தன் இயல்பான ேவைலகள் 
ெசய்வதாக மாற்ற ேவண்டும். 
“விேரசனத்தால் வாதந் தாழும் 
வமனத்தால் பித்தந் தாழும் 
நசியஅஞ்சனத்தால் கபந் தாழும்.” 
அதிகrத்த பித்தத்ைத தன்னிைலப்படுத்த வாந்தி மருத்துவம் ெசய்தல் 
ேவண்டும். பாண்டு ேநாயில் ேநாயாளி ேசார்வாகவும், தளர்வுடனும் இருப்பதால் 
வாந்தி முைற மருத்துவமானது ெகாடுப்பதில்ைல. 
உணவு 
ேநாய் ெதாடக்கத்தில் பசிையத்தூண்டக்கூடியதும், உடலின் குருதிைய 
ெபருக்கக்கூடியதுமான உணவும் எளிதில் ெசrக்கக்கூடியதாகேவ இருத்தல் 
ேவண்டும். 
கீைர வைககள் 





கத்தrப் பிஞ்சு, முருங்ைகப் பிஞ்சு, வாைழக்கச்சல், அவைரப் பிஞ்சு. 
பழங்கள் 
ெகாடிமுந்திrைக, சாத்துக்குடி, ஆப்பிள், அத்திப்பழம், மாதுைளப் பழம், 
ெநல்லி. 





The commonest nutritional deficiency disorder present throughout the world is 
iron deficiency anaemia. 
Body is formed by solids and fluids. The fluid part is more than two third of 
the whole body water forms most of the fluid part of the body. 
Blood is a connective tissue in fluid form. It is considered as the fluid of life, 
because it carries oxygen from lungs to all parts of the body and carbon dioxide from 
all parts of body to the lungs.It is known as the fluid of growth because it carries 
nutritive substances from the digestive system and hormones from endocrine gland to 
all the tissues.The blood is also called the fluid of health because it protects the body 
against the diseases and gets rid of the waste products and unwanted substances by 
transporting them to the excretory organs like kidneys. 
Blood contains iron in the form of haemoglobin and as cytochromes etc. Any 
form of iron deficiency cause anaemia. 
 
PROPERTIES OF BLOOD 
COLOUR: 
 Blood is red in colour. 
 Arterial blood is scarlet red because it contains more oxygen 
 Venous blood is purple red because of more carbon dioxide 
VOLUME: 
Average volume of blood in  
 5 litre in a normal adults 
 450 ml in a new born babies (it increases during growth and reaches 5 litre at 
the time of puberty)  
 4.5 litre in females 
SPECIFIC GRAVITY: 
            Total blood: 1.052 - 1.061 
            Blood cells: 1.092  - 1.101 






Blood is five times more viscous than water due to red blood cells and plasma 
proteins 
COMPOSITION OF BLOOD: 
Blood contains the blood cells which are called formed elements and the liquid 
portion known as plasma.  
 Blood consists of a solid protein 45% and a fluid protein 55%  
 Solid protein constitutes RBC,WBC and platelets  
 Fluid portion is plasma  
 
BLOOD CELLS: 
 Blood cells are of three types 
 Red blood cells or erythrocytes 
 White blood cells or leucocytes 
 Platelets ot thrombocytes 
 
FUNCTIONS OF BLOOD: 
1. NUTRITIVE FUNCTION:            
Nutritive substances like glucose, amino acid, lipids and vitamins derived 
from digested food are absorbed from gastrointestinal tract and carried by blood to 
different parts of the body for growth and production of energy.  
2. RESPIRATORY FUNCTION:              
Transport of respiratory gases is done by blood. It carries oxygen from alveoli 
of lungs to different tissues and carbon dioxide from tissues to alveoli.  
3. EXCRETORY FUNCTION:                
Waste products formed in the tissues during various metabolic activities are 
removed by blood and carried to the excretory organs like kidney, skin, liver, etc. for 
excretion.  
 
4. TRANSPORT OF HORMONES AND ENZYMES:             
Hormones which are secreted by ductless glands are released directly into the 
blood. The blood transports these hormones to their target organs/ tissues. Blood also 




5. REGULATION OF WATER BALANCE:    
Water content of the blood is freely interchangeable with interstitial fluid. This 
helps in the regulation of water content of the body.  
6. REGULATION OF ACID BASE BALANCE:              
Plasma proteins and hemoglobin act as buffers and help in the regulation of 
acid -base balance. 
7. REGULATION OF BODY TEMPERATURE:            
Because of the high specific heat of blood, it is responsible for maintaining the 
thermoregulatory mechanism in the body, i.e. the balance between heat loss and heat 
gain in the body.  
8. STORAGE FUNCTION: 
Water and some important substances like proteins, glucose, sodium and 
potassium are constantly required by the tissues. Blood serves as a readymade source 
for these substances. And, these substances are taken from blood during the condition 
like starvation, fluid loss, electrolyte loss, etc.  
9. DEFENSIVE MECHANISM: 
Blood plays an important role in the defense of the body. The white blood 
cells are responsible for this function. Neutrophils and monocytes engulf the bacteria 
by phagocytosis. Lymphocytes are involved in development of immunity. Eosinophils 
are responsible for detoxification, disintegration and removal of foreign proteins.  
 
RED BLOOD CELLS 
Red blood cells are the non-nucleated formed elements in the blood. Red 
blood cells are also known as erythrocytes. The red colour of the red blood cells is 
due to the presence of colouring pigment called hemoglobin. RBCs plays a vital role 
in transport of respiratory gases.RBCs are larger in number compared to the other two 
cells namely white blood cells and platelets. 
NORMAL VALUE 
The RBCs count ranges between 4 and 5.5 millions/cu mm of blood 
                In adult males  -5 millions/cu mm 






Normal Shape : Disc shaped and biconcave (Dumb-bell shaped).  
Normal Size : 7.2µ (6.9 – 7.4µ) in diameter. 
Thickness : Periphery-2.2µ (Thicker)  
   Centrally - 1 µ (Thinner)  
Surface Area  : 120sq.µ  
Volume     : 90 -95cu. µ 
ERYTHROPOIESIS: 
Erythropoiesis is the process of the origin, development and maturation of 
erythrocytes. 
SITE OFERYTHROPOIESIS: 
IN FETAL LIFE: 
In fetal life, the erythropoiesis occurs in three stages: 
1. Mesoblasticstage 
During the first two months of intrauterine life, the RBCs are produced from 
mesenchyme of yolk sac. 
2. Hepaticstage 
From third months of intrauterine life, liver is the main organ that produces 
RBCs.Spleen and lymphoid organs are also involved in erythropoiesis. 
3. Myeloid stage 
During the last three months of intrauterine life, the RBCs are produced from red 
bone marrow and liver. 
IN NEWBORN BABIES, CHILDREN AND ADULTS 
1. Up to the age of 20 years:RBCs are produced from red bone marrow of all bones. 
2. After the age of 20 years:RBCs are produced from membranous bones like 
vertebra, sternum, ribs, scapula,iliac bones and skull bones and from the ends of 
the  long bones. After 20 years of the age, the shaft of the long bones becomes 
yellow bone marrow because of fat deposition and loose the erythropoietic 
function. 
 In adults, liver and spleen may produce the blood cells if the bone marrow is 
destroyed or fibrosed. Colletively bone marrow is almost equal to liver in size and 





PROCESS OF ERYTHROPOIESIS: 
STEM CELLS:  
 The stem cells are the primitive cells in the bone marrow, which give rise to 
all the blood cells. Stem cells are defined as a cell which is capable of both self-
renewal and differentiation.  
 Pluripotent haemopoietic stem cells (PHSC) are derived from stem cells. 
PHSC are defined cells that can give rise to cells of all groups of haemopoietic cells 
like myeloid cells and lymphoid cells.  
 In the early stages, the PHSC are not designates to form a particular type of 
blood cell, and it is also not possible to determine the blood cell to be developed from 
these cells , hence the name uncommitted PHSC.  
 In adults only a few number of these cells are present. Best source of the cells 
is the umbilical cord blood.  
 When the cells are designated to form a particular type of blood cells the 
uncommitted PHSCs are called committed PHSCs.  
Committed PHSCs are of two types: 
1. Lymphoid stem cells (LSC) - which gives rise to Lymphocytes and natural 
killer (NK) cells 
2. Colony forming blastocytes- Which gives rise to myeloid cells. Myeloid cells 
are the blood cells other than lymphocytes. When grown in cultures these cells 
form colonies hence the name colony forming blastocytes.   
 
The different units of colony forming cells are:  
I. Colony forming unit – Erythrocytes (CFE-E). The Cells of this unit develop 
into erythrocytes. 
II. Colony forming unit granulocytes –Monocytes (FU-GM). These cells give rise 
to granulocytes (Neutrophils, Basophils and Eosinophils and Monocytes)  
III. Colony forming unit- Megakaryocytes (CFU-M). Platelets are formed from 
these cells 
 
CHANGES DURING ERYTHROPOIESIS:  
 The Cells of CFU-E pass through different stages finally become matured 
RBCs. During these changes four important changes are noticed.  
a) Reduction in size of the cells  
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b) Disappearance of nucleoli and nucleus  
c) Appearance of haemoglobin  
d) Changes in the staining properties of the protoplasm.  
 
STAGES OF ERYTHROPOIESIS:  
Various stages between CFU-E cells and matured RBCs are  
1. Proerythroblast  
2. Early normoblast  
3. Intermediate normoblast  
4. Late Normoblast  
5. Reticulocyte  
6. Mature Erythrocyte 
 
                            Stages of erythropoiesis 
FACTORS NECESSARY FOR ERYTHROPOIESIS: 
 General factors 
 Maturation factors 




General factors necessary for erythropoiesis are   
 Erythropoietin   
 Thyroxine  
 Hemopoietic growth factor  
 Vitamins-B, C, D and E  
 
Maturation factors  
 Vitamin B12(Cyanocobalamin)  
 Intrinsic factor of castle  
 Folic acid  
Vitamin B12 (Cyanocobalamin)  
 Vitamin B12 is called extrinsic factor because it is obtained mostly from diet. 
Vitamin B12is stored mostly in the liver and in small quantity in muscle.When 
necessary, it is transported to the bone marrow to promote maturation of RBCs.  
Intrinsic factor of castle  
 The extrinsic and intrinsic factors are together called haematinic principle.  
Folic acid  
 It is also essential for maturation. It is required for the synthesis of DNA. In 
the absence of folic acid the synthesis of DNA decreases causing failure of 
maturation.This leads to anaemia. 
 
Factors necessary for Haemoglobin formation:  
 Various materials are essential for the formation of haemoglobin in the RBCs.  
Such factors are,   
1. First class protein and aminoacids  
2. Iron: It is necessary for the formation of heme part of the haemoglobin   
3. Copper: It is necessary for the absorption of iron from the gastrointestinal 
tract.  
4. Cobalt and nickel: It is essential for the utilization of iron during haemoglobin 
formation.  
5. Vitamins: Vitamin C, Riboflavin, nicotinic acid and pyridoxine is also 




LIFE SPAN AND FATE OF RBC:-  
 Average life span of red blood cells is about 120 days.The senile red blood 
cells are destroyed in reticulo-endothelial system.  
 When the cells become older the cell membrane becomes more and more 
fragile. So these cells are destroyed while trying to squeeze through the capillaries. 
The destruction occurs mostly in the capillaries of the spleen because the splenic 
capillaries have a thin lumen. So the spleen is usually called “Grave yard” of red 
blood cells.  
 Daily 10 % of RBCs, which are senile, are destroyed in normal young healthy 





 Hemoglobin is the iron containing coloring matter of red blood cell. It is a 
chromoprotein forming 95% of dry weight of RBC and 30% to 34% of wet weight. 
Function of hemoglobin is to carry the respiratory gases, oxygen and carbon dioxide. 





NORMAL HEMOGLOBIN CONTENT 
 Average hemoglobin content in blood is 14 to 16 g/dL. However, the value 
varies depending upon sssthe age and sex of the individual.  
 
AGE 
 At birth Hb level  : 25g/dL  
 After 3rd month  : 20g/dL   
 After 1 year   : 17g/dL   
 From puberty onwards : 14 to 16g/dL  
 At the time of birth, hemoglobin content is very high because of increased 
number of RBCs  
SEX 
        In adult males : 15g/dL  
        In adult females : 14.5 g/dL   
 
FUNCTIONS OF HEMOGLOBIN 
 Transport of respiratory gases  
 Oxygen from the lungs to tissues  
 Carbon dioxide from tissues to lungs 
 Buffer action                  
 Hemoglobin acts as a buffer and plays an important role in acid- base balance 
 
STRUCTURE OF HAEMOGLOBIN   
 Haemoglobin is a conjugated protein. It consists of a protein combined with an 
iron containing pigment in heme. The protein part is globin and the iron containing 
pigment is heme. 
 Heme also forms a part of structure of myoglobin (oxygen binding pigment in 
muscles) 
 Neuroglobin(Oxygen binding pigment in brain) 
 
Iron: 




 The pigment part is called porphyrin. It is formed by four pyrole ring called I, 
II, III, IV. The Pyrole rings are attached to one another by methane (CH4) bridge  
The iron is attached to   
                 -N of the each pyrole ring and   
                 -N of the globin molecule  
Globin: 
This contains four polypeptide chains  
 α chains-2  
 β chains -2  
 
TYPES OF HAEMOGLOBIN  
Haemoglobin is of two types  
1. Adult haemoglobin- HbA  
2. Fetal haemoglobin- HbF  
 There are structural differences between the two types of haemoglobin. In 
adult haemoglobin, the globin contains two α chains and two β chains. In fetal 
haemoglobin, there are two α chains and two γ chains instead of β chains. 
 
SYNTHESIS OF HEMOGLOBIN 
 Synthesis of hemoglobin actually starts in proerythroblastic stage. However, 
hemoglobin appears in the intermediate normoblastic stage only. Production of 
hemoglobin is continued until the stage of reticulocyte.  
 The heme protein of hemoglobin is synthesized in mitochondria. And the 





SYNTHESIS OF HEME: 
 
 
Heme is synthesized from succinyl-Co A and the glycine. The sequence of 
events in synthesis of hemoglobin: 
1. First step in heme systhesis takes place in the mitochondrian. Two molecules 
of succinyl-Co A combines with two molecules of glycine and condense to 
form α aminolevulinic acid (ALA) by ALA synthase.  
2. ALA is transported to the cytoplasm. Two molecules of ALA combine to form 
porphobilinogenin the presence of ALA dehydratase.  
3. Porphobilinogen converted into urophobilinogen - I by urophobilinogen - I 
synthase 
4. Uroporphobilinogen - I is converted into uroporphobilinogen - III 
byporphobilinogen - III cosynthase.  
5. From uroporphobilinogen - III, a ring structure called coporphobilinogen - III 
is formed by uroporphobilinogen decarboxylase.  
6. Coprophobilinogen - III is transported back to the mitochondrion, where it is 
oxidized to form protoporphyrinogen - IX by coproporphyrinogen oxidase.  
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7. Protoporphyrinogen - IX is converted into protoporphyrin - IX by 
protoporphyrinogen oxidase.  
8. Protoporphyrin - IX combines with iron to formheme in the presence of 
ferrochelatase.  
 
FORMATION OF GLOBIN 
 Polypeptide chains of globin are produced in the ribosomes. There are four 
types of polypeptide chains namely, alpha, beta, gamma and delta chains. Each of 
these chains differs from others by the amino acid sequence. Each globin molecule is 
formed by the combination of 2 pairs of chains and each chain is made of 141 to 146 
amino acids. Adult hemoglobin contains two alpha chains and two beta chains. Fetal 
hemoglobin contains two alpha chains and two gamma chains.  
 
CONFIGURATION 
 Each polypeptide chain combines with one heme molecule. Thus, after the 
complete configuration, each hemoglobin molecule contains 4 polypeptide chains and 
4 heme molecules.  
 
SUBSTANCES NECESSARY FOR HEMOGLOBIN SYNTHESIS 
 Various materials are essential for the formation of hemoglobin in the RBC.  
DESTRUCTION OF HEMOGLOBIN 
 After the lifespan of 120 days, the RBC is destroyed in the reticuloendothelial 
system, particularly in spleen and the hemoglobin is released into plasma. Soon, the 
hemoglobin is degraded in the reticuloendothelial cells and split into globin and heme.  
 Globin is utilized for the resynthesis of hemoglobin. Heme is degraded into 
iron and porphyrin. Iron is stored in the body as ferritin and hemosiderin, which are 
reutilized into a green pigment called biliverdin. In human being, most of the 
biliverdin is converted into a yellow pigment called bilirubin. Bilirubin and biliverdin 





BREAKDOWN OF HEMOGLOBIN 
 
 
NORMAL VALUES OF HAEMOGLOBIN OF DIFFERENT AGE GROUP 
AGE GROUP MEAN(G/dl) RANGE(G/dl) 
Cord blood 17.1 13.7-20.5 
7 days 18.8 14.6-23.0 
20 days 15.9 11.3-20.5 
45 days 12.7 9.5-15.9 
75 days 11.4 9.6-13.2 
120 days 11.9 9.9-13.9 
1 year 12.2 10-13.0 
5 year 12.5 12-13 
10 year 13.5 13-14 
Older 15 14-15 
 
 
PACKED CELL VOLUME AND BLOOD INDICES: 
Packed cell volume (PCV) is the haematocrit value expressed as the 





BLOOD INDICES:  
Blood indices are specifically meant for erythrocytes. Blood indices have got 
diagnostic value in determining the type of anaemia.  
DIFFERENT BLOOD INDICES:  
Following are the different blood indices   
1.  Mean Corpuscular Volume (MCV)  
Mean Corpuscular Volume is the average volume of single red blood cells and 
it is expressed in cubic microns(cu.µ)  
MCV = ࡼ࡯ࢂ ࢏࢔ ૚૙૙૙࢓࢒ ࢕࢘ ૚૙૙࢓࢒ ൈ૚૙ࡾ࡮࡯ ࢏࢔ ࢓࢏࢒࢒࢏࢕࢔࢙ ࢖ࢋ࢘ ࢉ࢛.࢓࢓  
 
2. Mean Corpuscular Haemoglobin (MCH)  
Mean Corpuscular Haemoglobin is the quantity or amount of haemoglobin 
present in one red blood cell. It is expressed in micrograms or pictograms(pg)  
MCH = ࡴࢇࢋ࢓࢕ࢍ࢒࢕࢈࢏࢔ ࢏࢔ ࢍ࢓࢙ ࢖ࢋ࢘ ૚૙૙૙࢓࢒ ࢕ࢌ ࢈࢒࢕࢕ࢊൈ૚૙૙ൈ૚૙ࡾ࡮࡯ ࢉ࢕࢛࢔࢚ ࢏࢔ ࢓࢏࢒࢒࢏࢕࢔࢙ ࢖ࢋ࢘ ࢉ࢛.࢓࢓  
 
3. Mean Corpuscular Haemoglobin Concentration (MCHC)  
It is the amount of haemoglobin expressed in relation to volume of one blood 
cell. So the unit of expression is percentage.  
MCHC = ࡴࢇࢋ࢓࢕ࢍ࢒࢕࢈࢏࢔ ࢏࢔ ࢍ࢘ࢇ࢓࢙ ࢖ࢋ࢘ ૚૙૙࢓࢒ ࢕ࢌ ࢈࢒࢕࢕ࢊ ൈ૚૙ࡼ࡯ࢂ ࢏࢔ ૚૙૙ ࢓࢒ ࢕ࢌ ࢈࢒࢕࢕ࢊ  
4.  Colour Index:  
This is the ratio between the percentage of the haemoglobin and the 
percentage of red blood cells in the blood.  
  CI = ࡴࢇࢋ࢓࢕ࢍ࢒࢕࢈࢏࢔ ࢏࢔ %ࡾ࡮࡯ ࢏࢔ %  
 All the above mentioned blood indices are reduced in iron deficiency anaemia.  
NORMAL VALUES:  
Packed Cell Volume (PCV):  
3 month – 10 years   -36.0±5.0%  
11 – 15 years                           -39.0 ± 5.0%  
Mean Corpuscular Volume (MCV)  
3 months -10 years             -80 cu.µ  




Mean Corpuscular Haemoglobin  (MCH)  
3months – 10years                -27 picograms   
11- 15 years                            -28 picograms  
Mean Corpuscular Haemoglobin  Concentration (MCHC)  
3months to 10 years                -34g/dl  
11- 15 years                            -34g/dl   
Reticulocytes:  
6 months – 6 years                 -1.0%  
7- 12 years   -1.0%  
IRON :  
Iron is one of the most essential trace elements in the body. Heme is the most 
predominant iron containing substance. Iron is important for the formation of 
haemoglobin, myoglobin, cytochromes and other components of respiratory enzymes 
like cytochrome oxides, catalase and peroxidase.  
 
NORMAL VALUE AND DISTRIBUTION OF IRON IN THE BODY:  
The total quantity of iron in the body is about 4 grams. The approximate 
distribution of iron in the body is as follows:  
In the haemoglobin     – 65 - 68%  
In the muscle as myoglobin    –4%  
As intracellular oxidative heme compound  –1%  
In the plasma as transferrin    –1%  
Stored in the reticuloendothelial system  –25 – 30%  
BIOCHEMICAL FUNCTION:  
1. Haemoglobin and myoglobin are required for the transport of O2and CO2.  
2. Cytochromes and certain non heme proteins are necessary for electron 
transport chain and oxidative phosphorylation.  
3. Peroxidase, the lysosomal enzyme, is required for phagocytosis and killing of 
bacteria by neutrophils.  
4. Iron is associated with effective immunocompetence of the body.  
Daily iron requirement in different age group.  
Males 11 years to 17 years   - 12mg/day.  




DIETARY IRON:  
The dietary iron comes from two sourses, heme and non heme, the latter being 
the major source of iron in diet and is found in varying degrees in all foods of plant 
origin.  
Heme iron is present in meet fish and poultry, but the intake of these product 
is generally low. Heme iron is better absorbed than non heme iron and is not 
influenced by dietary factors.  
Breast milk even in spite of low levels of iron (0.5mg/lit) has a better 
absorption and bioavailability as compared to cow’s milk. Good source of iron in diet 
include pulses, dhals, green leafy vegetables, dates, nuts, jaggery, meat and fish. Poor 
sources of iron in the diet include milk, wheat, polished rice. Administration of 50mg 
of vitamin C increases iron absorption by two folds.  
 
FACTORS AFFECTING IRON ABSORPTION:  
1. Acidity, ascorbic acid and cysteine promote iron absorption.  
2. In iron deficiency anaemia, iron absorption is increased to 2- 10 times that of 
normal.  
3. Small peptides and amino acids favour iron uptake  
4. Phytates found in cereals and oxalates found in leafy vegetables interfere with 
iron absorption.  
5. A diet with high phosphate content decreases iron absorption while too low 
phosphate promotes.  
6. Impaired absorption of iron is absorbed in malabsorption syndrome such as 
steatorrhoea.  
7. In patients with partial or total surgical removal of stomatch and or intestine, 















Iron is mainly absorbed in the stomach and duodenum. Iron is mostly found in 
foods in ferric form. Fe3+ bound to proteins or organic acids. In the acid medium 
provided by gastric hydrochloric acid the Fe3+is released from foods. Reducing 
substances such as ascorbic acid (vitamin c) and cysteine convert ferric iron (Fe3+) to 
ferrous form Fe2+.Iron in ferrous form is soluble and readily absorbed.  
 
Iron in the mucosal cells:  
The iron Fe2+entering the mucosal cells by absorption is oxidized to ferric 
(Fe3+) form by the enzyme ferroxidase.  
Fe3+ then combine with apoferritin to form ferritin which is the temporary 
storage form of iron and is present in gastrointestinal mucosa, bone marrow, liver and 




TRANSPORT OF IRON IN THE PLASMA: 
 
 
The iron liberated from the ferritin of mucosal cells enters the plasma in 
ferrous state, it is plasma in ferrous state, it is plasma in ferrous state, it is oxidized to 
ferric form by a copper containing protein, ceruloplasmin. Another cuproprotein 
ferroxidase II also help for the conversion of Fe2+to Fe3+.  
Ferric iron that binds with a specific iron binding proteins namely transferrin 
or siderophilin.  
Each transferrin molecule can bind with two atoms of ferric ion Fe3+. The 
plasma transferrin can bind with 400mg of iron /dl plasma. This plasma is known as 
total iron binding capacity(TIBC) of plasma.  
Hemosiderin is another iron storage protein, accumlate in the spleen and liver 
when the supply of iron is in excess of body demands. 
 
IRON IS A ONE WAY SUBSTANCE  
Iron is very efficiently utilized and reutilized by the body. Further, iron losses 
from the body are minimal which may occur through bile, sweat, hair loss etc. Iron is 









Anaemia is present when the haemoglobin level in the blood is two standard 
deviations below the mean for the particular age and sex.  
Physiological definition of anaemia is a condition in which tissue hypoxia 
occurs due to inadequate oxygen carrying capacity of blood.  
 
WHO criteria for diagnosis of anaemia.  
Children of 6 months- 6years <11  
Children of 6 years -14 years <12  
 
Grading of Anaemia :  
WHO grades anaemia according to haemoglobin level as follows.  
 Hb between 10gram and cut off point for age    - Mild   
 Hb between 7-10gram            - Moderate   
 Hb under 7gram                     - Severe  
 
CLASSIFICATION:   
A. Based on the Morphology  
Based on the red cell size haemoglobin content and red cell indices anaemia are 
classified as follows.  
1. Microccytic hypochromic anaemia  
2. Normocytic normochromic anaemia  
3. Macrocytic normocytic anaemia  
4. Macrocytic hypochromic anaemia  
B .Based on Etiopathogenesis  
1. Nutritional anaemia   
2. Haemolytic anaemia   
3. Haemorrage   
4. Bone marrow suppression   
5. Infections   
6. Miscellaneous  
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I. Disorders of impared RBC production 
A. Deficiency anemia   
I. Iron deficiency anaemia  
II. Nutritional megaloblastic anaemia (Vit B12 and folate deficiency)  
III. Mixed deficiency states (Dimorphic anaemia)  
B. Bone marrow failure  
1. Aplastic anaemia   
 Congenital and acquired  
 Acquired  
2. Selective red cell aplasia:  
 Congenital   
 Diamond blacfan anaemia  
 Acquired   
  Eg. Transient erythroblastopenia of childhood.  
3. Marrow replacement   
 Myelofibrosis  
 Osteopetrosis  
 Maligancies  
4. Impaired erythropoiesis production   
 Chronic renal failure  
 Hypothyroidism and hypopituitarism  
 Chronic malnutrition  
5. Miscellanaeous:   
 Congenital dyserythropoietc anaemia’s  
 Erythropoietic porphyria  
 
II. Disorders of increased RBC production:   
A. RBC membrane defects   
 Eg. .Hereditary spherocytosis  
B. Defects of Haemoglobin synthesis   
i. Quantitative(Thalaseemia)  
 Alpha   
 Beta  
 Delta  
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ii. Qualitative (Haemoglobinopathesis)  
Eg. Sickle cell disease HbE disease  
iii. Combined –Quantitative and Qualitativedefects  
Hbs beta thalassemia  
C. Defects of RBC enzymes  
 G-6-PD deficiency  
 Pyruate kinase deficiency  
D. Acquired defects:  
a) Immune haemolysis  
 Warm and cold antibody type   
 ABO and Rh incompactibility  
b) Infections  
 Malaria  
 Kala azar  
 Acute bacterial infections  
 
PATHOLOGICAL RED BLOOD CELLS IN ANAEMIA:  
In anaemia, many kinds of abnormal red cells including nucleated forms are 
seen in the circulation. These abnormal cells are,  
I. Anisocytosis(Variation in the size of RBC)  
Macrocytosis, Microcytosis, Normocytosis   
II. Poikilocytosis (Variation in shape of RBC)  
Ovalocytosis, Spherocytosis, sickle cells  
III. Polychromatophilia (Irregularity in stainig)   
This indicates an increase in immature red cells in circirculation and occurs in 
the following forms  Normoblasts, patchy staining of the cells, Punctate Basophilia 








IRON DEFICIENCY ANAEMIA 
 
Iron Deficiency Anaemia is the most common and wide spread nutritional 
disorder present throughout the world, but its prevalence is higher in 
developingcountries.  
WHO estimates the number of anemic people worldwide to be a staggering 
two billion people and that approximately 50% of all anaemia can be attributed to iron 
deficiency.  
Malaria, HIV/AIDS, hookworm infestations, schistomiasis and other 
infections such as tuberculosis are particularly important factors contributing to the 
high prevalence of anaemia in some areas.  
40-50% of children and adult women were anaemic and that accounted for 
about 50% of anaemia in school children and women 80% in preschool children (2-5 
years old)  
 
According to third national family health survey (NFHS3)  
79% of Indian children have anaemia including  
 7% of urban children and 84% of these in rural areas  
 
STRUCTURE OF THE RED CORPUSCLES IN IRON DEFICIENCY 
ANAEMIA:  
 In iron deficiency anaemia the red blood corpuscles are decreased or normal in 
number and haemoglobin content of the red blood corpuscles is reduced. In blood 
smear, the red cells appear pale with a large central pale area and many of the red 
blood cells appear to be smaller than the normal.  
This type of anaemia is called Hypochromic and microcytic anaemia.  
ETIOLOGY:-  
The Etiology varies with the age, sex and country of residence of the patients.  
 
ETIOLOGICAL FACTORS IN IRON DEFICIENCY ANAEMIA:-  
Increased physiological requirements:  




Decreased iron stores:  
Premature babies and twins  
Increased demand during:  
Low birth weight, prematurity, adolescence, recovery from PEM.  
Poor intake of dietary iron:  
Exclusive milk diet, restriction of calories.  
Poor absorption:  
Celiac disease, giardiasis, drug intake  
Excess loss of iron:  
Blood loss during childbirth, gastrointestinal haemorrhage, faecal blood loss 
due to hookworm infestation, genitourinary bleed.   
Iron malabsorption:  
 Starch and clay eating produce malabsorption of iron and iron deficiency anaemia.  
 PICA increases the risk of helminths  
 Delayed weaning, infection and lead poisioning  
 Sprue, non-tropical sprue, chronic diarrhea, mille induced enteropathy 
 Rarely errors in metabolism as  
 Sideroblastic anaemia   
 Idiopathic pulmonary hemosiderosis  
 Congenital transferrin deficiency where iron gets stored in the body rather 
than being utilized for erythropoiesis  
Diminish absorption of iron:  
Phytates, oxalates, phosphates, carbonates and tannates  
Growth  
Iron deficiency anaemia is more in children between the ages of 6 months to 2 
years and from 11 to 16 years due to spurts of growth during these periods.  
Pathophysiology  
Diminished dietary absorption in proximal small intestine or excessive loss of 
body iron can result in iron deficiency  
Iron deficiency anaemia develops when the supply of iron to the bone marrow 





Iron is required for multiple metabolic process including, 
 Oxygen transport  
 DNA synthesis  
 Electron transport  
 In severe iron deficiency, the iron containing enzymes are low and this can 
affect immune and tissue function.  
 Iron deficiency anaemia can result in diminished growth /and learning and 
have serious consequences in children.  
 Healthy new born infants have a total body iron of 250mg (Approximately 80 
parts permillion ppm) this decreases to approximately 60 ppm in the first 6 
months of the life.  
 Body iron is regulated carefully by absorptive cells in the proximal small 
intestine, which alter iron absorption to match body losses of iron.  
 Breast milk iron content is more bioavailable than cow’s milk.  
 Beside this fact, infants who consume cow’s milk have more iron deficiency 
because bovine milk has a higher concentration of calcium which competes 
with iron for absorption and they may have gastrointestinal blood loss due to 
cow’s milk allergy.  
 
STAGES OF IRON DEFICIENCY ANAEMIA  
On the basis of biochemical and haematological changes iron deficiency is 
graded into three stages  
Stage I – Depletion of iron store  
Ferritin is decreased, transferrin saturation, serum iron and haemoglobin are 
normal  
Stage II- Depletion of transport 
Iron transferrin saturation and serum iron also reduced. Haemoglobin is 
normal.  
Stage III – State of IDA  
Frank features of IDA  
The flow of iron to erythroid marrow is impared to cause reduction in 
haemoglobin concentration with a progressive microcytic hypochromic anaemia 




CLINICAL FEATURES:-   
Symptoms:  
 Irritability  
 Anorexia   
 Easy fatigability  
 Tiredness/ weakness   
 Diarrhoea is often present   
 Leg cramps   
 Palpitations  
 Inability to concentrate, somnolence, giddiness.  
 Features of causative condition for example epigastric pain (Peptic ulcer)  
 Constipation  
 History of PICA  
 Lack of memory  
Signs:  
 Eyes- Pallor in conjuntiva  
 Nails- Pallor, Koilonychias (spoon shaped nails) and platynychia (flat nails)  
 Hair- Dry, lusterless, excess loss of scalp hair    
 Mouth-  Bald, atrophy of tongue papillae glossitis, angular stomatitis  
 Abdomen – Mild hepatomegaly is common in children.  
 
ROLE OF IRON DEFICIENCY ANAEMIA IN VARIOUS SYSTEMS  
Cardiovascular system:-  
Dyspnoea and palpitations are common symptoms but in very severe anaemia 
the patient may get congestive cardiac failure. Haemic murmurs are commonly heared 
in anaemic patients.  
Respiratory system:-  
Dyspnoea and respiratory infections  
Central nervous system:-  
Symptoms include faintness, giddiness, headache, lack of concentration and 
drowsiness with severe anaemia, clouding of consciousness, numbness and sometimes 




Renal system:-   
Slight protenuria may be present with severe anaemia  
Gastrointestinal system:-  
 Anorexia is the commonest system nausea, flatulence and constipation may 
also occur slight to moderate smooth hepatomegaly is common in severe anaemia. 
Liver may become tender. In certain cases of iron deficiency anaemia, spleen may be 
enlarged.  
 
DIFFERENTIAL DIAGNOSIS OF MICROCYTIC HYPOCHROMIC 
ANAEMIA  
 Thalassaemia  
 Pyridoxine deficiency  
 Lead poisioning  
 Chronic infection   
 Sideroblastic anaemia  
 Congenital atransferrinemia  
 Copper deficiency   
 G6PD deficiency  
 
COMPLICATIONS:  
 Infections are more common in iron deficiency anaemia, especially those of 
respiratory, gastrointestinal and urinary tracts.  




 Complete blood count with blood indexes  
 RBC count decreased, WBC  count normal  
 Low –mean corpuscular volume (MCV), mean corpuscular 
haemoglobin(MCH) and mean corpuscular haemoglobin concentration 
(MCHC)  
 Peripheral blood smear –RBCs are microcytic hypochromic and show 
anisocytic, poikilocytosis  
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 Normal reticulocyte count   
 Serum iron level -  Less than 60g/dl  
 Total iron binding capacity(TIBC) - >350g/dl  
 Transferrin saturation - <16% (Normal range-25% -50% )  
 Serum ferritin - Low  
 Free erythrocyte protoporphyrins(FEP)- increased  
 Normal 30 – 40% g/dl  
 70g/dl indicate IDA  
 Stainable iron in marrow- low  
 FEP/Haemoglobin ratio increases.  Normal ratio 60 : 1  
 Iron containing enzymes such as monoamine oxidase, catalase, cytochrome 
peroxidases will be – low  
 Investigation to determine the cause  of anaemia,  
 Stool examination – stools for occult blood, ova, cyst (hookworms).  
 Gastrointestinal studies for bleeding, polyp, etc.-   
 Barium meal examination, upper/ lower GI endoscopy, etc.    
 
DIAGNOSIS:  
Following criteria are essential to diagnose iron deficiency anaemia  
 History of inadequate intake of dietary iron and blood loss if any.  
 Hypochromic and microcytic structure of red blood cells.  
 Low serum iron, increased total iron binding capacity.  
 Platelet count is either normal or raised.  
 Haemoglobin estimation variably reduced  
 Reduced mean cell volume  
 Erythrocyte count may be normal or reduced less than haemoglobin level 
would suggest. 
 Serum ferritin level is reduced  







 Treat the cause  
 Increase the iron intake   
 Increase iron absorption 
 Overall correction of nutrition with food articles rich in iron is most 
important. Meat, liver, green leafy vegetables, onion, grapes, and jaggery 
are good source of iron.  
 There are two forms of dietary iron heme and non heme.  
 Vitamin c help absorb the non heme iron. Food containing non heme iron 
and the vitamin C rich food are eaten at the same meal.        
 
PREVENTION:  
This is a condition which can be prevented easily by supplementing iron rich 
foods. This involves the following measures:  
 Eating diet with a wide variety of iron containing food  
 Fortification of articles of food such as bread, salt, wheat and flour  
 Improvement of personal hygiene  
 Avoiding open air defecation (ankylostomiasis)  
 Wearing foot wear  
 Frequent deworming   


















S. NO. NAME BOTANICAL NAME PARTS USED QUANTITY 
1 Karisalankanni Eclipta prostrata Dried whole plant 4 thola 
2 Mookirattai Boerhaevia diffusa Dried whole plant 1 thola 
3 Chukku Zingiber officinale Dried rhizome 1 thola 
4 Milagu Piper nigrum Dried seed 1 thola 
5 Thippili Piper longum Dried fruit 1 thola 
6 Kadukkaai Terminalia chebula Dried fruit coat 1 thola 
7 Nellikkaai Phyllanthus emblica Dried fruit 1 thola 
8 Thandrikkaai Terminalia bellerica Dried fruit coat 1 thola 
9 Maramanjal Coscinium fenestratum Dried wood 1 thola 
10 Thaniya Coriandrum sativum Dried fruit 1 thola 
11 Athimathuram Glycyrrhiza glabra Dried root 1 thola 
12 Karunseeragam Nigella sativa Dried seed 1 thola 
13 Thalisapathiri Abies spectabilis Dried leaves 1 thola 
14 Elam Elettaria cardamomum Dried seed 1 thola 







SOURCE OF RAW DRUGS  
                The above said raw drugs are purchased from a well reputed country shop 
.The raw drugs will be authenticated by the  Head of the department of Medicinal 
Botany ,at Govt. siddha medical college, chennai. The raw drugs are purified and the  
medicine is prepared  in Gunapadam laborotary of GSMC, Chennai.The prepared 
medicine is again authenticated by the  Head of the department of Gunapadam.  
PURIFICATION OF THE RAW DRUGS:  
1. Karisalai:Eclipta alba, Clean  the leaves with pure cloth and remove the 
rotten leaves. 
2. Kadukai:Terminalia chebulla, Soak the kadukai in rice water(kazhuneer) over 
night, remove the yellowish tint of the water and seed and dry it. 
3. Nellikai:Phyllanthus emblica, Boil it with milk, remove the seed and dry it. 
4. Thaandrikai:Terminalia bellarica, Soak it in Pandanus odoratissimus 
(Thaludhalai), juice for three hours (1Samam) remove the seed and dry it. 
5. Sukku:Zingiber officinalis, Double the propotion of lime stone[calcium 
carbonate] solution is poured and boiled for three hours, then wash it, dry and 
remove the peel.  
6. Milagu:Piper nigrum, Soak it in sour butter milk for three hours. 
7. Thippili:Piper longum, Soak it in plumbago zeylanica, (Kodiveli) leaf juice 
for twenty four minutes (1 Nazhigai) and dry it sun. 
8. Mara manjal:Coscinium fenestratum, Remove the peel cut it into pieces and 
dry it in sunlight.  
9. Karunjeragam:Nigella sativa, Dry it in sunlight &fry it like as golden  yellow 
colour. 
10. Seeragam:Cuminum cyminum, Dry it in sunlight &fry it like as golden  
yellow colour. 
11. Athimathuram:Glycrrhiza glabra, Wash with clean water and Remove the 
peel cut it into pieces. 
12. Mookkirattai:Boerhaavia diffusa, Clean the leaves with pure cloth and 
remove the rotten leaves. 
13. Thalisa pathiri:Abies spectabilis, Clean the leaves with pure cloth and 
remove the rotten leaves. 
14. Dhania:Coriandrum sativum, Boil Kothumali seed with Hotwater & dry it in 
sunlight. 




INGREDIENTS OF KARISALANKANNI CHOORANAM 
   




   
Zingiber officinale                Piper nigrum                         Piper longum 
 
  
   
        




   
 
Cuminum cyminum                     Nigella sativa                     Abies spectabilis 
   
  Coscinium fenestratum            Elettaria cardamomum       Coriandrum sativum 
METHOD OF PREPARATION  
 The above mentioned drugs are purified properly as said above and they are 
dried in shade & made into fine powder  
DRUG STORAGE: The drug thus prepared is stored in a clean and dry glass bottles. 
DOSE: 200mg – 500mg twice a day 
ADJUVANT: Honey 
DURATION: 28 days 
 
PROPERTIES OF THE DRUG 
1. Karisaalai 
Botanical name  :Eclipta prostrata 
English name   :Trailing eclipta 
Family   :Compositae 
Organoleptic characters 
Taste    :kaipu 
Potency   :veppam 
Division   :karpu 
Parts used   :leaves, flowers 
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Chemical constituents :Dithienylacetylene 
Action                  :cholagogue, emetic, tonic, aphrodisiac, hepato 
      tonic 
Uses    :jaundice, pruritis, scabies, enlargement of  
      spleen, liver. 
Pothu gunam  
“குரற்கம்மற் காமாைல குட்டெமாடு ேசாைப 
யுற்றபாண்டு பன்ேனா ெயாழிய- நிரற்ெசான்ன 
ெமய்யாந் தகைரெயாத்த மீளிண்ணு நற்புலத்துக் 
ைகயாந் தகைரெயாத்தக் கால்.” 
 
2. Mookirattai 
Botanical name : Boerhaavia diffusa 
English name : Spreading hog-weed 
Family : Nyctaginaceae 
Organoleptic characters 
Taste : Kaippu 
Potency : Veppam 
Division : Kaarppu 
Parts used : Herb, root 
Chemical constituents : Purine nucleoside (hypoxanthine-9- 
  arabinofuranoside), Rotenoids   
  (boeravinonesA and B),  Punarnavoside.  
Action : Stomachic, laxative, diuretic, diaphoretic, 
  expectorant. 
Uses                        :  Cures dropsy, ascities, asthma, heart disease, 
  renal calculi. 
Pothu gunam  
“சதீ மகற்றுந் தினவடக்குங் காந்திதரும் 
வாத விைனைய மடிக்குங்காண்- ேபதி 
ெகாடுக்குமாைத உண்டாக்காற் ேகாமள்ேம! பித்தம் 





Botanical name : Zingiber officinale 
English name : Dry ginger 
Family : Zingiberaceae 
Organoleptic characters 
Taste : Kaarppu 
Potency : Veppam 
Division  : Kaarppu 
Parts used : Rizhome 
Chemical constituents : β-Bisabolene, ar-curcumene, α-farnesene 
  Phellandrene and zingiberene. 
Action : Carminative, aromatic, stimulant, increases  
  prostaglandins 
Uses :  Cures cold, cough, indigestion, peptic ulcer,  
  flatulence. 
 
Pothu gunam           
“சூைலமந்தம் ெநஞ்ெசrப்பு ேதாடேமப் பம்மழைல 
மூலம் இைரப்பிருமல் மூக்குநீர்- வாலகப 
ேதாடமதி சாரந் ெதாடர்வாத குன்மநீர்த் 
ேதாடம்ஆ மம்ேபாக்குஞ் சுக்கு.“ 
4. Milagu 
Botanical name : Piper nigrum 
English name : Black pepper 
Family : Piperaceae 
Organoleptic characters 
Taste : Kaippu, kaarppu 
Potency : Veppam 
Division : Kaarppu 
Parts used : Dried unripe fruit 
Chemical constituents : Piperine, piperidine, clavicin. 
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Action : Carminative, antiperiodic, resolvent, anti-
  pyretic 
Uses : Cures dyspepsia, flatulence, colic, worms, 
   ascities, asthma, gonorrhoea. 
 
Pothu gunam           
“சதீசுரம் பாண்டு சிேலத்மங் கிராணிகுன்மம் 
வாதம் அருசிபித்தம் மாமூலம்- ஓதுசன்னி 
யாசமபஸ் மாரம் அடன்ேமகம் காசமிைவ 
நாசங் கறிமிளகினால் 
ேகாணுகின்ற பக்கவலி குய்யவுேரா கம்வாத 
ேசாணிதங்க ழுத்திற்குள் ேதான்றுேநாய்- காணrய 
காதுேநாய் மாதர்குன்மங் காமாைல மந்தெமன்றரீ் 
ஏதுேநாய் காயிருக்கில் ஈங்கு.” 
 
5. Thippili 
Botanical name       : Piper longum 
English name          : Dried catkins, long-pepper 
Family                     : Piperaceae 
Organoleptic characters 
Taste                        : Kaarppu 
Potency                    : Veppam 
Division                   : Inippu 
Parts used               : Immature berries, stems, roots. 
Chemical constituents : Piperine, piperolactam A and B, piperadione. 
Action                     : Stimulant, carminative, expectorant, diuretic 
Uses                        : Cures cold, cough, asthma, hoarseness, hiccup, 




Pothu gunam           
“இருமல் குன்மம் இைரப்பு கயப்பிணி 
ஈைள பாண்டு சந்யாசம் அேராசகம் 
ெபாருமல் ஊைத சிரப்பிணி மூர்ச்ைசேநாய் 
பூrக் குஞ்சல ேதாடம் பீலிகமும் 
வரும லப்ெபருக் ேகாடு மேகாதரம் 
வாதம் ஆதிமுத் ேதாடஞ் சுரங்குளிர் 
ெபருமாைலப்புr ேமகப் பிடகமும் 
ேபருந் திப்பிலிப் ேபரங்குைரக்கேவ.” 
 
6. Kadukkaai 
Botanical name       :  Terminalia chebula 
English name          : Chebulic myrobalan, myrobalan 
Family                     : Combretaceae 
Organoleptic characters 
Taste                        :  Thuvarppu 
Potency                    : Veppam 
Division                   : Inippu 
Parts used               : Dried fruits, galls 
Chemical constituents : Gallic acid 
Action                     : Astringent, purgative, alterative, stomachic. 
Uses                        : Cures worms, fever, cough, asthma, urinary 
  disease, piles, hiccup, vomiting. 
 
Pothu gunam          
“தாைட கழுத்தக்கி தாலுகுறி யிவிடப் 
பீைடசி லிபதமுற் ேபதிமுடம்- ஆைடெயட்டாத் 
தூலமிடி புண்வாத ேசாணிதங்கா மாைல 






Botanical name       : Emblica officinalis 
English name          : Emblicmyrobalan, Indian gooseberry 
Family                     : Euphorbiaceae 
Organoleptic characters 
Taste                        : Pulippu, thurvarppu, inippu 
Potency                    : thatpam 
Division                   : inippu 
Parts used               : Dried fruit, nut or seed, leaves, rootbark,  
  flowers. 
Chemical constituents : Procyanidin, prodelphinidin. 
Action                     : Refrigerant, diuretic, laxative, astringent. 
Uses                        : Cures jaundice, inflammation of lungs,  
  hiccup, dyspepsia, nausea,  vomiting. 
 
Pothu gunam           
“பித்தமன ைலயம் பீநசம்வாய் நீர் வாந்தி 
மந்தமலக் காடும் மயக்கமுமில்- ஒத்தவுரு 
வில்லிக்கா யம்மருங்கா ெமன்னாட்கா லந்ேதர்ந்ேத 
ெநல்லிகா யம்மருந் துண ீ
 
ெநல்லிக்காய்க் குப்பித்தம் நீங்கு மதன்புளிப்பால் 
ெசல்லுேம வாதமதிற் ேசர்துவரால்- ெசால்லுைமயம் 
ஓடுமிைதச் சித்தத்தில் உன்ன அனலுடேன 
கூடுபிற ேமகமும் ெபாங் கூறு.” 
 
8. Thandrikkaai 
Botanical name : Terminalia bellarica 
English name : Belericmyrobalans. 





Taste : Thuvarppu 
Potency : Veppam 
Division : Inippu 
Parts used : Fruits 
Chemical constituents : Punicalin, punicalagin, geraniin, granatin B. 
Action : Astringent, tonic, laxative, expectorant. 
Uses : Cures cough, hoarseness, sore throat, dropsy. 
Pothu gunam   
“சிலந்திவிடம் காமியப்புண் சழீான ேமகங் 
கலந்துவரும் வாதபித்தங் காேலா- டலர்ந்துடலில் 
ஊன்றிக்காய் ெவப்ப முதிரபித் துங்கரக்குந் 
தான்றிக்காய் ைகயிெலடுத் தால் 
 
ஆணிப்ெபன் ேமனிக் கழகும் ஒளியுமிகும் 
ேகாணிெகாள்வாதபித்தக் ெகாள்ைகேபாம்-தானிக்காய்             
ெகாண்டவர்க்கு ேமகமறும் கூற அனற்றணியும் 
கண்டவர்க்கு வாதம்ேபாம் காண்”. 
 
9. Maramanjal 
Botanical name  : Coscinium fenestratum 
English name  : Tree turmeric 
Family  : Menispermaceae 
Organoleptic characters 
Taste  : Kaippu 
Potency  : Veppam 
Division  : Kaarppu 
Parts used  : Stem 
Chemical constituents  : Berlambine, dihydroberlambine and   
   noroxyhydrastinine. 
Action  : Febrifuge, stomachic, tonic 




Pothu gunam           
“அழன்றகண மூலம் அருசி யுடேன 
உழன்ற கணசுரமும் ஒடுஞ்- சுழன்றுள்ேள 
வறீுசுர முந்தணியும் வசீுமர மஞ்சளுக்குத் 
ேதறு ெமாழியன்ேம! ெசப்பு”. 
 
10. Thaniya 
Botanical name  : Coriandrum sativum 
English name  : Coriander 
Family  : Umbelliferae 
Organoleptic characters 
Taste  :  Kaarppu 
Potency  : Seetha veppam 
Division  :  Kaarppu 
Parts used  : Fruits, leaves. 
Chemical constituents : Gnaphaloside A and B, quercetin,   
   isohamnetin, rutin and luteolin. 
Action  : Aromatic, stimulant, tonic, carminative,  
   anti- diabetic. 
Uses  : Cures diabetes, flatulence, colic, sore throat,  
   vertigo. 
Pothu gunam    
“ெகாத்துமல்லி ெவப்பம் குளிர்காய்ச்சல் 
சர்த்திவிக்கல் தாகெமாடு தாதுநட்டம்- கத்திெயழும் 
வாத விகார்மடர் வங்கர்த்த பிவிரணம் 






Botanical name  : Glycyrrhiza glabra 
English name  :  Liquorice 
Family  : Fabaceae 
Organoleptic characters 
Taste  : Inippu 
Potency  : Thatpam 
Division  : Inippu 
Parts used  : Root and Rhizomes 
Chemical constituents : Hexanoic acid, γ-nonalactone, cumic alcohol, 
   indole, anethole. 
Action  : Tonic, demulcent, expectorant, diuretic, mild 
   laxative, anti-arthritic. 
Uses  : Cures anemia, menorrhagia-metrorrhagia,  
   hematemesis. 
 
Pothu gunam  
“கத்தியr முப்பிணியால் வருபுண் தாகங் 
கண்ேணாய்உன் மாதம்விக்கல் வலிெவண்குட்டம் 
பித்தம்எலும் புருக்கி கிrச்சரம் ஆவர்த்த 
பித்த மதமூர்ச்ைச விடபாகம் ெவப்பந் 
தத்திவரு வாதேசாணிதங்கா மாைல 
சருவவிடங் காமியேநாய் தாது நட்டங் 
குத்திருமல் ஆசியங்கம் இதழ்ேநாய் இந்து 
குயப்புணும்ேபாம் மதூகெமனக் கூறூங்காேல”. 
 
12. Karunseeragam 
Botanical name  : Nigella sativa 
English name  :  Small fennel or black cumin 




   Organoleptic characters 
Taste  :  Kaippu 
Potency  : Veppam 
Division  : Kaarppu 
Parts used  : Dried fruits and seeds. 
Chemical constituents : Nigellimine N-oxide, nigellicine, saponins. 
Action  : Diuretic, stomachic, stimulant, carminative,  
   anthelmintic. 
Uses  : Cures obstinate hiccup, fever, diarrhea, skin  
   diseases. 
 
Pothu gunam    
“கருஞ்ச ீரகத்தான் கரப்பெனாடு புண்ணும் 
வருஞ்சிராய்ப் பீநசமு மாற்றும்- அருந்தினால் 
காய்ச்சல் தைலவலியுங் கண்வலியும் ேபாமுலகில் 
வாய்ச்ச மருந்ெதன்ேவ ைவ.” 
 
13. Thaalisapathiri 
Botanical name       : Abies spectabilis 
English name : Himalayan yew 
Family : Coniferae 
Organoleptic characters 
Taste : Kaarppu 
Potency : Veppam 
Division : Kaarppu 
Parts used : Leaves, volatile oil 
Chemical constituents : Betuloside, methyl betuloside, n-triacontanol, β-
  sitosterol.  
Action : Carminative, expectorant, stomachic, tonic,  
  antilithic. 
Uses : Cures breast cancer, asthma, haemoptysis,  




Pothu gunam   
“நாசி களப்பிணிகள் நாட்பட்ட காசஞ்சு 
வாசம் அருசி வனமங்கால்- வசீிவரு 




Botanical name : Elettaria cardamomum 
English name : Cardamom 
Family : Scitaminaceae 
Organoleptic characters 
Taste : Kaarppu 
Potency : Veppam 
Division : Kaarppu 
Parts used : Dried ripe seeds, oil from fruits. 
Chemical constituents : α-terpineol, myrcene, heptane, limonene,  
  menthone. 
Action : Aromatic, stimulant, carminative,   
  stomachic, diuretic. 
Uses : Cures stomach complaints, diarrhoea, atonic 
  dyspepsia. 
Pothu gunam  
“ெதாண்ைட வாய்கவுள் தாலுகு தங்களில் 
ேதான்றும் ேநாயதி சாரம்பன் ேமகத்தால் 
உண்ைட ேபால்எழுங் கட்டி கிrச்சரம் 
உழைல வாந்தி சிலந்தி விஷஞ்சுரம் 
பண்ைட ெவக்ைக விதாகேநாய் காசமும் 
பாழஞ் ேசாமப் பிணிவிந்து நட்டமும் 
அண்ைட யீைளவன் பித்தம் இைவக்ெகல்லாம் 






Botanical name : Cuminum cyminum 
English name : Cumin seed, caraway seed. 
Family : Umbelliferae 
Organoleptic characters  
Taste : Kaarppu 
Potency : Thatpam 
Division : Inippu 
Parts used : Fruit and seed. 
Chemical constituents : Cuminaldehyde 
Action : Carminative, aromatic, stomachic, stimulant, 
  astringent. 
Uses : Cures hoarseness of voice, dyspepsia, chronic 
  diarrhea. 
Pothu gunam   
“பித்தெமனு மந்திrையப் பின்னிப் படுத்தியவன் 
சத்துருைவ யுந்துறந்து சாதித்து- மத்தெனனும் 
ராசைனயு மீெவன்று நண்ைபப் பலபடுத்தி 




PRECLINICAL SAFETY STUDIES 
BIO-CHEMICAL ANALYSIS 
 
PREPARATION OF EXTRACT:  
2 gm of the Karisalankaani chooranam is taken in a 100 ml beaker and 20 ml 
of distilled water is added. The solution is boiled for 10 minutes, cooled and then 




NO EXPERIMENT OBSERVATION INFERENCE
I. TEST FOR FREE RADICALS 
1. 
Test for Chloride                                         
2 ml of extract is added with dilute nitric 
acid till the effervescence ceases. Then 2 
ml of silver nitrate solution is added 
Presence of white 
precipitate Present 
2. 
Test for Phosphate:                                     
2 ml of the extract is treated with 2ml of 
Ammonium molybdate solution and 2 ml 
of concentrated nitric acid 
Absence of yellow 
precipitate Absent 
3. 
Test for Carbonate:                                     
2 ml of the extract is treated with 2 ml of 
magnesium sulphate solution 
Absence of white 
precipitate Absent 
4. 
Test for Sulphide:                                        
1 gm of the substance is treated with 2 ml 
of concentrated Hydrochloric acid 
 
Absence of  Rotten 
egg smelling Absent 
5. 
Test for Sulphate:                                        
2ml of the above prepared extract is taken 
in a test tube to this added 2ml of 4% 
ammonium oxalate solution 
Absent of white 
preciptate Absent 
6. 
Test for Nitrate                                            
1 gm of the substance is heated with 
copper turnings and concentrated 
sulphuric acid and viewed the test tube 
vertically down 
Absence  of reddish 
brown gas Absent 
7. 
Test for Nitrite 
3 drops of the extract is placed on a filter 
paper. On that, 2 drop of Acetic acid and 2 
drops of Benzidine solution is placed 
Absence of yellowish 




Test for Borate                                             
2 pinches of the substance is made into 
paste by using Sulphuric acid and Alcohol 
(95%) and introduced into the blue flame 
Absence of green 




II. TEST FOR BASIC RADICALS 
9. 
Test for copper                                             
One pinch of the substance is made into 
paste with concentrated Hydrochloric acid 
in a watch glass and introduced into the 
Non luminous part of the flame 
Absence of Bluish 






Test for  iron 
To the 2 ml of extract, 2 ml of 
Ammonium thiocyanate solution is added 
Presence of blood red 
colour Present 
11. 
Test for zinc                                                  
To the 2 ml of extract Sodium hydroxide 
solution is added in drops to excess 
Absence of white 
precipitate Absent 
12. 
Test for calcium 
2 ml of the extract is added with 2 ml of 4 
% Ammonium oxalate solution 
Presence of white 
precipitate Present 
13. 
Test for magnesium                                    
2ml of extract sodium hydroxide solution 
is added in drops to excess 
Absence of white 
precipitate Absent 
14. 
Test for potassium                                       
A pinch of  substance is treated with 2 ml 
of sodium nitrite solution and then treated 
with 2 ml of Cobalt nitrate in 30% glacial 
Acetic acid 
Absence of yellow 
precipitate Absent 
15. 
Test for sodium                                            
2 pinches of the substance is made into 
paste by using Hydrochloric acid and 
introduced into the blue flame 
Absence of yellow        
colour flame Absent 
16. 
Test for starch 
2 ml of extract is treated with weak iodine 
solution 
Blue colour is 
obtained Present 
17. 
Test for reducing sugar               5 ml of 
Benedict’s qualitative solution is taken in 
a test tube and allowed to boil for 2 
minutes and added 10 drops of the extract 
and again boiled for 2 minutes. The colour 
changes are noted 
Green colour is 
obtained Present 
18. 
Test for tannic acid                                      
The extract is treated with ferric chloride 
solution 
Absence of Blue 
black precipitate Absent 
 
RESULTS:  
The trial drug Karisalankanni chooranam contains   
 Acid radical: Chloride  
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PHYTOCHEMICAL ANALYSIS 
Test for alkaloids: 
Mayer's Test:  To the test sample, 2ml of mayer's reagent was added, a dull 
white precipitate revealed the presence of alkaloids. 
Test for coumarins:  
To the test sample, 1 ml of 10% sodium hydroxide was added. The presence of 
coumarins is indicated by the formation of yellow color. 
Test for saponins:  
To the test sample, 5 ml of water was added and the tube was shaken 
vigorously. Copious lather formation indicates the presence of Saponins. 
Test for tannins:  
To the test sample, ferric chloride was added, formation of a dark blue or 
greenish black color showed the presence of tannins. 
Test for glycosides- Borntrager’s Test: 
Test drug is hydrolysed with concentrated hydrochloric acid for 2 hours on a 
water bath, filtered and the hydrolysate is subjected to the following tests. To 2 ml of 
filtered hydrolysate, 3 ml of choloroform is added and shaken, choloroform layer is 






Test for flavonoids:  
To the test sample about 5 ml of dilute ammonia solution were been added 
followed by addition of few drops of conc. Sulfuric acid. Appearance of yellow color 
indicates the presence of Flavonoids. 
 
Test for phenols: 
Lead acetate test: 
To the test sample; 3 ml of 10% lead acetate solution was added.  A bulky 
white precipitate indicated the presence of phenolic compounds. 
Test for steroids:  
To the test sample, 2ml of chloroform was added with few drops of conc. 
Sulphuric acid (3ml), and shaken well. The upper layer in the test tube was turns into 
red and sulphuric acid layer showed yellow with green fluorescence. It showed the 
presence of steroids. 
Triterpenoids  
Liebermann–Burchard test: To the chloroform solution, few drops of acetic 
anhydride was added then mixed well. 1 ml concentrated sulphuric acid was added 
from the sides of the test tube, appearance of red ring indicates the presence of 
triterpenoids. 
Test for Cyanins 
A. Aanthocyanin: 
To the test sample, 1 ml of 2N sodium hydroxide was added and heated for 5 
min at 1000C. Formation of bluish green colour indicates the presence of anthocyanin. 
Test for Carbohydrates - Benedict’s test: 
To the test sample about 0.5 ml of Benedic’s reagent is added. The mixture is 
heated on a boiling water bath for 2 minutes. A characteristic coloured precipitate 
indicates the presence of sugar. 
Proteins (Biuret Test) 
To extracts 1% solution of copper sulphate was added followed by 5% 
















Test for Coumarins, Phenol, Tanins, Saponin and Protein 
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Nature fine powder 
Odor Strongly Aromatic 









Solubility Profile of KC 
 
 
S.No Solvent Used Solubility / Dispersibility 
1 Chloroform Soluble 
2 Ethanol Soluble 
3 Water Soluble 
4 Hexane Insoluble 
5 Ethyl acetate Soluble 
6 DMSO Partially Soluble 
 
Percentage Loss on Drying 
Test drug was accurately weighed in evaporating dish .The sample was dried 
at 105oC for 5 hours and then weighed. 
Determination of Total Ash 
Test drug was accurately weighed in silica dish and incinerated at the furnace 
a temperature 400 ºC until it turns white in color which indicates absence of carbon. 






Determination of Acid Insoluble Ash 
The ash obtained by total ash test will be boiled with 25 ml of dilute 
hydrochloric acid for 6mins. Then the insoluble matter is collected in crucible and 
will be washed with hot water and ignited to constant weight. Percentage of acid 
insoluble ash will be calculated with reference to the weight of air-dried ash. 
Determination of Alcohol Soluble Extractive 
Test sample was macerated with 100 ml of Alcohol in a closed flask for 
twenty-four hours, shaking frequently during six hours and allowing it to stand for 
eighteen hours. Filter rapidly, taking precautions against loss of solvent, evaporate 25 
ml of the filtrate to dryness in a tared flat bottomed shallow dish, and dry at 105ºC, to 
constant weight and weigh. Calculate the percentage of alcohol-soluble extractive 
with reference to the air-dried drug. 
Determination of Water Soluble Extractive 
Test sample was macerated with 100 ml of chloroform water in a closed flask 
for twenty-four hours, shaking frequently during six hours and allowing it to stand 
and for eighteen hours. Filter rapidly, taking precautions against loss of solvent, 
evaporate 25 ml of the filtrate to dryness in a tared flat bottomed shallow dish, and 
dry at 105ºC, to constant weight and weigh. Calculate the percentage of water-soluble 
extractive with reference to the air-dried drug. 
 
Final Test report KC 
S.No Parameter Mean (n=3) SD 
1.        Loss on Drying at 105 °C (%) 2.433  ± 0.30 
2.        Total Ash (%)  17.6  ± 0.7 
3.        Acid insoluble Ash (%) 0.26  ± 0.034 
5.        Alcohol Soluble Extractive (%) 12  ± 1.55 










                Test sample was subjected to thin layer chromatography (TLC) as per 
conventional one dimensional ascending method using silica gel 60F254, 7X6 cm 
(Merck) were cut with ordinary household scissors. Plate markings were made with 
soft pencil. Micro pipette were used to spot the sample for TLC applied sample 
volume 10-micro liter by using pipette at distance of 1 cm at 5 tracks. In the twin 
trough chamber with the specified solvent system After the run plates are dried and 
was observed using visible light Short-wave UV light 254nm and light long-wave UV 
light 365 nm 
 
HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY ANALYSIS 
HPTLC method is a modern sophisticated and automated separation technique 
derived from TLC. Pre-coated HPTLC graded plates and auto sampler was used to 
achieve precision, sensitive, significant separation both qualitatively and 
quantitatively. High performance thin layer chromatography (HPTLC) is a valuable 
quality assessment tool for the evaluation of botanical materials efficiently and cost 
effectively. HPTLC method offers high degree of selectivity, sensitivity and rapidity 
combined with single-step sample preparation. In addition it is a reliable method for 
the quantitation of nano grams level of samples. Thus this method can be 
conveniently adopted for routine quality control analysis. It provides chromatographic 
fingerprint of phytochemicals which is suitable for confirming the identity and purity 
of medicinal plant raw materials.  
Chromatogram Development 
It was carried out in CAMAG Twin Trough chambers. Sample elution was 
carried out according to the adsorption capability of the component to be analysed. 
After elution, plates were taken out of the chamber and dried. 
Scanning 
Plates were scanned under UV at 366nm. The data obtained from scanning 
were brought into integration through CAMAG software. Chromatographic finger 
print was developed for the detection of phytoconstituents present in each extract and 
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CAMAG TLC SCANNER III 
Aluminium Coated Silica Gel – Merck 
Chloroform: n-Butanol: Methanol: Water: Acetic 
Acid (4:1:1:0.5:0.5) 
Analysis Type Third Party Analysis 











 HPTLC finger printing analysis of the sample reveals the presence of three 
prominent peaks corresponds to presence of three versatile phytocomponents present 
with in it. Rf value of the peaks ranges from 0.08 to 0.81. Further the peak 1 and 3 












TEST FOR SPECIFIC PATHOGEN 
 
Methodology: 
One part of the test sample was dissolved in 9 mL of sterile distilled water and 
the test sample was directly inoculated in to the specific pathogen medium (EMB, 
DCC, Mannitol ,Cetrimide) by pour plate method. The plates were incubated at 37oC 
for 24 - 72h for observation. Presence of specific pathogen identified by their 
characteristic color with respect to pattern of colony formation in each differential 
media. 
 
Detail of Specific Medium and their abbreviation 
Organism Abbreviation Medium  
E-coli EC EMB Agar 
Salmonella SA Deoxycholate agar 
Staphylococcus Aureus ST Mannitol salt agar 
Pseudomonas 
Aeruginosa 
PS Cetrimide Agar 
 
Observation 
No growth was observed after incubation period. Reveals the absence of 
specific pathogen 
Result 
No growth / colonies were observed in any of the plates inoculated with the 
test sample. 
 
Organism Specification Result Method 
E-coli Absent Absent  
As per AYUSH 
specification 
Salmonella Absent Absent













































STERILITY TEST BY POUR PLATE METHOD 
 
Objective  
The pour plate techniques were adopted to determine the sterility of the 
product. Contaminated / un sterile sample (formulation) when come in contact with 
the nutrition rich medium it promotes the growth of the organism and after stipulated 
period of incubation the growth of the organism was identified by characteristic 
pattern of colonies. The colonies are referred to as Colony Forming Units (CFUs).   
Methodology 
Test sample was admixed with sterile distilled water and the mixture were 
been used for the sterility evaluation. About 1ml of the test sample was inoculated in 
sterile petri dish to which about 15 mL of molten agar 45oC were added. Agar and 
sample were mixed thoroughly by tilting and swirling the dish. Agar was allowed to 
completely gel without disturbing it. (about 10 minutes). Plates were then inverted 
and incubated at 37o C for 24-48 hours. Grown colonies of organism was then 
counted and calculated for CFU.  
   
Observation 
No growth was observed after incubation period. Reveals the absence of 
specific pathogen 
Result 
No growth / colonies were observed in any of the plates inoculates with the 
test sample. 
Test Result Specification As per 
AYUSH/WHO 
Total Bacterial Count Absent NMT 105CFU/g As per AYUSH 
specification 












Std. Deviation 34.99 
Std. Error 14.28 
 
REPORT 
Microscopic observation of the particle size analysis reveals that the average 
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 Aflatoxin B1 




Standard samples was dissolved in a mixture of chloroform and acetonitrile (9.8 : 0.2) to 
obtain a solution having concentrations of 0.5 µg per ml each of aflatoxin B1 and aflatoxin G1 and 
0.1 µg per ml each of aflatoxin B2 and aflatoxin G2.  
Test solution: Concentration 1 µg per ml 
Procedure 
Standard aflatoxin was applied on to the surface to pre coated TLC plate in the volume 
of2.5 µL, 5µL, 7.5 µL and 10 µL. Similarly the test sample was placed and Allow the spots to dry 
and develop the chromatogram in an unsaturated chamber containing a solvent system 
consisting of a mixture of chloroform, acetone and isopropyl alcohol (85 : 10 : 5) until the solvent front 
has moved not less than 15 cm from the origin. Remove the plate from the developing chamber, mark 
the solvent from and allow the plate to air-dry. Locate the spots on the plate by examination under 




Aflatoxin Sample KC AYUSH Specification 
Limit 
B1 Not Detected - Absent 0.5 ppm 
B2 Not Detected - Absent 0.1 ppm 
G1 Not Detected - Absent 0.5 ppm 
G2 Not Detected - Absent 0.1 ppm 
 
Result: 
The results shown that there was no spots were been identified in the test sample loaded on 
TLC plates when compare to the standard , which indicates that the sample were free from 





HEAVY METAL ANALYSIS 
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HEAVY METAL ANALYSIS BY AAS 
Standard: Hg, As, Pb and Cd – Sigma 
Methodology 
Atomic Absorption Spectrometry (AAS) is a very common and reliable 
technique for detecting metals and metalloids in environmental samples. The 
total heavy metal content of the sample was performed by Atomic Absorption 
Spectrometry (AAS) Model AA 240 Series. In order to determination the heavy 
metals such as mercury, arsenic, lead and cadmium concentrations in the 
testitem. 
Sample Digestion 
Test sample was digested with 1mol/L HCl for determination of arsenic 
and mercury. Similarly for the determination of lead and cadmium the sample 
were digested with 1mol/L of HNO3. 
Standard reparation 
As & Hg- 100 ppm sample in 1mol/L HCl 










BDL- Below Detection Limit 
Report and Inference 
 Results of the present investigation have clearly shows that the sample has 














Mercury 253.7 nm 0.3 1 ppm
Lead 217.0 nm 0.5 10 ppm
Arsenic 193.7 nm 0.25 3 ppm
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Extraction 
 Test sample were extracted with 100 ml of acetone and followed by 
homogenization for brief period. Further filtration was allowed and subsequent 
addition of acetone to the test mixture. Heating of test sample was performed using a 
rotary evaporator at a temperature not exceeding 40ºC until the solvent has almost 
completely evaporated. To the residue add a few milliliters of toluene R and heat 
again until the acetone is completely removed. Resultant residue will be dissolved 





Test Result Analysis of the Sample KC 
Pesticide Residue  
Sample KC 
 
AYUSH Limit (mg/kg) I.Organo Chlorine Pesticides 
Alpha BHC BQL 0.1mg/kg 
Beta BHC BQL 0.1mg/kg 
Gamma BHC BQL 0.1mg/kg 
Delta BHC BQL 0.1mg/kg 
DDT BQL 1mg/kg 
Endosulphan BQL 3mg/kg 
II.Organo Phosphorus Pesticides   
Malathion BQL 1mg/kg 
Chlorpyriphos BQL 0.2 mg/kg 
Dichlorovos BQL 1mg/kg 
III.Pyrethroid   
Cypermethrin BQL 1mg/kg 
 
BQL- Below quantification Limit  
 
Result:  
The results showed that there were no traces of pesticides residues such as 







ACUTE ORAL TOXICITY STUDY OF KARISALANKANNI CHOORANAM 
(OECD GUIDELINE – 423) 
 
Introduction: 
 The acute toxic class method is a stepwise procedure with the use of 3 animals 
of a single sex per step. 
 Depending on the mortality and/or the moribund status of the animals, on 
average 2-4 steps may be necessary to allow judgement on the acute toxicity 
of the test substance.  
 This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods.  
 The acute toxic class method is based on biometric evaluations with fixed 
doses, adequately separated to enable a substance to be ranked for 
classification purposes and hazard assessment.  
 In principle, the method is not intended to allow the calculation of a precise 
LD50, but does allow for the determination of defined exposure ranges where 
lethality is expected since death of a proportion of the animals is still the major 
endpoint of this test.  
 The method allows for the determination of an LD50 value only when at least 
two doses result in mortality higher than 0% and lower than 100%.  
 The use of a selection of pre-defined doses, regardless of test substance, with   
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency 
and repeatability.  
 
Principle of the Test:  
It is the principle of the test that based on a stepwise procedure with the use of 
a minimum number of animals per step, sufficient information is obtained on the 
acute toxicity of the test substance to enable its classification. The substance is 
administered orally to a group of experimental animals at one of the defined doses. 
The substance is tested using a stepwise procedure, each step using three animals of a 
single sex. Absence or presence of compound-related mortality of the animals dosed 
at one step will determine the next step, i.e. 
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− no further testing is needed 
− dosing of three additional animals, with the same dose  
− dosing of three additional animals at the next higher or the next lower dose 
level. 
The method will enable a judgment with respect to classifying the test 
substance to one of a series of toxicity classes. 
Methodology: 
Selection of Animal Species  
The preferred rodent species is the wistar albino rat, although other rodent 
species may be used. Healthy young adult animals are commonly used laboratory 
strains should be employed. Females should be nulliparous and non-pregnant. Each 
animal, at the commencement of its dosing, should be between 6 to 8 weeks old and 
the weight (150-200gm) should fall in an interval within±20 % of the mean weight of 
any previously dosed animals.  
 
Housing and Feeding Conditions 
The temperature in the experimental animal room should be 22ºC + 3ºC.  
Although the relative humidity should be at least 30% and preferably not exceed 70% 
other than during room cleaning the aim should be 50-60%. Lighting should be 
artificial, the sequence being 12 hours light, 12 hours dark. For feeding, conventional 
laboratory diets may be used with an unlimited supply of drinking water. Animals 
may be group-caged by dose, but the number of animals per cage must not interfere 
with clear observations of each animal. 
 
Preparation of animals:   
The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization 
to the laboratory conditions. 
 
Test Animals and Test Conditions:  
Sexually mature Female Wistar albino rats (150-200gm) were obtained from 
Kings institute,Guindy, Chennai. All the animals were kept under standard 
environmental condition (22±3°C).  The animals had free access to water and 




Preparation for Acute Toxicity Studies 
Rats were deprived of food overnight (but not water 16-18 h) prior to 
administration of the, KARISALANKANNI CHOORANAM.. 
The principles of laboratory animal care were followed and the Institutional 
Animal Ethical Committee approved the use of the animals and the study design 
IAEC No: LV/11/CLBMCP/2018 
 
Test Substance :  KARISALANKANNI CHOORANAM 
Animal Source :  Kings Institute, Guindy, Chennai.   
Animals :  Wister Albino Rats (Female-3+3) 
Age :  6-8 weeks 
Body Weight on Day 0 :  150-200gm. 
Acclimatization :  Seven days prior to dosing. 
Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals :  By cage number, animal number and individual  
  marking by using Picric acid. 
Numberofanimals : 3 Female/group,  
Routeofadministration  :   Oral  
Diet : Pellet feed supplied by Sai meera foods Pvt Ltd, 
  Bangalore 
Water : Aqua guard portable water in polypropylene bottles. 
Housing & Environment :  The animals were housed in Polypropylene cages 
   provided with bedding of husk. 
Housing temperature :  between 22ºC + 3ºC.   
Relative humidity :   between 30% and 70%, 
Air changes  :  10 to 15 per hour and  
Dark and light cycle  : 12:12 hours. 




Administration of Doses:  
KARISALANKANNI CHOORANAMwas suspended in lukewarm water and 
administered to the groups of wistar albino rats in a single oral dose by gavage using a 
feeding needle. The control group received an equal volume of the vehicle. Animals 
were fasted 12 hours prior to dosing. Following the period of fasting, the animals 
were weighed and then the test substance was administered. Three Female animals are 
used for each group. The dose level of 2000 mg/kg body weight was administered as 
single dose. After the substance has been administered, food was withheld for a 
further 3-4 hours. The principle of laboratory animal care was followed. Observations 
were made and recorded systematically and continuously as per the guideline after 
substance administration. The visual observations included skin changes, mobility, 
aggressively, sensitivity to sound and pain, as well as respiratory movements. Finally, 
the number of survivors was noted after 24 hrs and these animals were then monitored 
for a further 14 days and observations made daily. The toxicological effect was 
assessed on the basis of mortality. 
 
Observations:  
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the 
first 4 hours, and daily thereafter, for a total of 14 days, except where they need to be 
removed from the study and humanely killed for animal welfare reasons or are found 
dead. It should be determined by the toxic reactions, time of onset and length of 
recovery period, and may thus be extended when considered necessary. The times at 
which signs of toxicity appear and disappear are important, especially if there is a 
tendency for toxic signs to be delayed. All observations are systematically recorded 
with individual records being maintained for each animal. 
Observations include changes in skin and fur, eyes and mucous membranes, 
and also respiratory, circulatory, autonomic and central nervous systems, and 
somatomotor activity and behavior pattern. Attention was directed to observations of 
tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma. The principles 
and criteria summarized in the Humane Endpoints Guidance Document taken into 
consideration. Animals found in a moribund condition and animals showing severe 
pain or enduring signs of severe distress was humanly killed. When animals are killed 
for human reasons or found dead, the time of death was recorded.  
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Acute oral toxicity studyofKARISALANKANNI CHOORANAM 
Table 1: Dose finding experiment and its behavioral Signs of acute oral Toxicity 
 
Observation done: 
SL Group CONTROL Observation SL
Group 
TEST GROUP Observation 
1 Body weight Normal 1 Body weight Normally 
increased
2 Assessments of posture Normal 2 Assessments of posture Normal 
3 Signs of Convulsion Limb paralysis Normal 3
Signs of Convulsion 
Limb paralysis 
Absence of sign (-
) 
4 Body tone Normal 4 Body tone Normal 
5 Lacrimation Normal 5 Lacrimation Absence 
6 Salivation Normal 6 Salivation Absence 
7 Change in skin color No significant color change 7 Change in skin color 
No significant 
color change 
8 Piloerection Normal 8 Piloerection Normal 
9 Defecation Normal  9 Defecation 
Normal 
 
10 Sensitivity response Normal 10 Sensitivity response Normal 
11 Locomotion Normal 11 Locomotion Normal 
12 Muscle gripness Normal 12 Muscle gripness Normal 
13 Rearing Mild 13 Rearing Mild 









The animals will be observed closely for behaviour in the first four hours 
which  includes abnormal gait, aggressiveness, exophthalmos, ptosis, akinesia, 
catalepsy, convolusion, excitation, head twitches, lacrimation, loss of corneal 
reflex,loss of traction, piloerection  reactivity of touch, salivation, scratching, 
sedation, chewing,  head movements, sniffing, straub, tremor and writhes, diarrhea, 
leathery, sleep and coma.  
Body Weight:  
Individual weight of animals was determined before the test substance was 
administered and weights will be recorded at day 1, 7, and 14 of the study. Weight 
changes were calculated and recorded. At the end of the test, surviving animals were 
weighed and humanly killed. 
Food and water Consumption: 
 Food and water consumed per animal was calculated for control and the treated dose 
groups.  
Mortality: 
Animals were observed for mortality throughout the entire period. 
Results: 
 All data were summarized in tabular form, (Table-1-4) showing for each test 
group the number of animals used, the number of animals displaying signs of toxicity, 
the number of animals found dead during the test, description of toxic symptoms, 
weight changes, food and water intake 
No of animals in each group:3 
 
Table 2 (Observational study Results) 
No Dose mg/kg 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
1. Control + - - + - + - - - - - - - - - - - - - - 






1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming 5. Gripping 6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 
11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. 
Exophthalmos 17. Diarrhea 18. Writhing  
19. Respiration 20. Mortality. 
(+ Present, - Absent) 
 












1 6 14 
CONTROL 58.7 ± 1.22 59.2±2.16 60.2±3.14 
HIGH DOSE 58.2 ±1.30 60.6±2.70 61 ±2.64 
P value (p)* NS NS NS 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
Table 4: Food intake (gm/day) of Wistar albino rats group exposed to 





1 7 14 
CONTROL 84.03±2.12 86.2±2.26 88.6±4.16 






1 7 14 
CONTROL 244.1±65.70  246.3 ± 41.11 248.6 ±02.12 
HIGH DOSE 248.3± 4.64 250.7 ±3.22 252.2 ± 2.70 
P value (p)* NS NS NS 
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REPEATED DOSE 28-DAY ORAL TOXICITY (407) STUDY 
OFKARISALANKANNI CHOORANAM 
 
Test Substance :  KARISALANKANNI CHOORANAM  
Animal Source  :   TANUVAS, Madhavaram, Chennai.  
Animals :   Wister Albino Rats (Male -24, and Female-24)  
Age  :   6-8 weeks  
Body Weight  :   50-200gm.  
Acclimatization  :   Seven days prior to dose.  
Veterinary examination  :   Prior and at the end of the acclimatization period.  
Identification of animals :  By cage number, animal number and individual  
   marking by using Picric acid  
Diet  :   Pellet feed supplied by Sai Meera Foods Pvt Ltd,  
   Bangalore  
Water  :  Aqua guard portable water in polypropylene  
   bottles.  
Housing & Environment :   The animals were housed in Polypropylene cages  
   provided with bedding of husk.  
Housing temperature  :  between 22ºC + 3ºC.  
Relative humidity  :  between 30% and 70%,  
Air changes  : 10 to 15 per hour  
Dark and light cycle  :  12:12 hours.  
Duration of the study  :  28 Days.  
 
Table 5 
Groups No of Rats 
Group I Vehicle control (Water) 12(6male,6 female) 
Group II KCM- low dose X (50mg) 12 (6male,6 female) 
Group III KCM- Mid dose 4X (200mg) 12 (6male,6female) 
Group IV KCM- High dose 8X(400 mg) 12(6male,6female) 





Randomization, Numbering and Grouping of Animals:  
48 Wistar Albino Rats (24M + 24F) were selected and divided into 4 groups. Each 
group consist of 12 animals (Male -6, and Female-6). First group treated as a control 
and other three group were treated with test drug (low, mid, high) for 28 days. 
Animals were allowed acclimatization period of 7 days to laboratory conditions prior 
to the initiation of treatment. Each animal was marked with picric acid. The females 
were nulliparous and non-pregnant. 
Justification for Dose Selection: 
 As per OECD guideline three dose levels were selected for the study. They are 
low dose (X), mid dose (4X), high dose (8X). X is calculated by multiplying the 
therapeutic dose (500 mg) and the body surface area of the rat (0.018). i.e X dose is 
(50mg/kg), 4X dose is (200mg/kg), 8X dose is (400mg/kg). 
 
Preparation and Administration of Dose: 
 Karisalankanni chooranam suspended in with water, It was administered to 
animals at the dose levels of X, 4X, 8X. The test substance suspensions were freshly 
prepared every two days once for 28 days. The control animals were administered 
vehicle only. The drug was administered orally by using oral gavage once daily for 28 
consecutive days. 
Observations: 
Experimental animals were kept under observation throughout the course of 
study for the following 
Body Weight:  
 Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study.  
Food and water Consumption:  
 Food and water consumed per animal was calculated for control and the 
treated dose groups.  
Clinical signs:  
 All animals were observed daily for clinical signs. The time of onset, intensity 





 All animals were observed twice daily for mortality during entire course of 
study.  
Necropsy:  
 All the animals were sacrificed by excessive anesthesia on day 29. Necropsy 
of all animals was carried out.  
Laboratory Investigations:  
 Following laboratory investigations were carried out on day 29 in animals 
fasted over- night. Blood samples were collected from orbital sinus using sodium 
heparin (200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for 
Hematology as anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 
minutes.  
Haematological Investigations:  
 Haematological parameters were determined using Haematology analyzer.  
Biochemical Investigations:  
 Biochemical parameters were determined using auto-analyzer.  
Histopathology:  
 Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group 
than the low, then the mid dose group will also be examined. Organs will be collected 
from all animals and preserved in 10% buffered neutral formalin for 24 h and washed 
in running water for 24 h. The organ sliced 5 or 6μm sections and were dehydrated in 
an auto technicon and then cleared in benzene to remove absolute alcohol. Embedding 
was done by passing the cleared samples through three cups containing molten 
paraffin at 50°C and then in a cubical block of paraffin made by the “L” moulds. It 
was followed by microtome and the slides were stained with Haematoxylin-eosin red.  
Statistical analysis: 
 Findings such as body weight changes, water and food consumption, 
hematology and blood chemistry were subjected to One-way ANOVA followed by 
dunnet t test using a computer software programme – Graph pad version 7. All data 





 Repeated Dose 28- day oral toxic study of KARISALANKANNI 
CHOORANAM  




1 7 14 21 28 
CONTROL 235.2±18.46 236.5 ± 35.10 236.6 ± 45.60 238.7±56.16 238.4 ± 66.15
LOW DOSE 248.2 ± 65.24 250.7 ± 66.28 254.6± 55.34 256 ±56.34 256.8± 35.36
MID DOSE 252.4± 18.34 253.3 ± 16.24 253.4 ± 14.12 255.2 ±15.20 256.4 ± 54.10
HIGH DOSE 261.6± 62.24 261.4±42.22 262.4 ± 52.24 263 ± 54.28 264 ± 74.60 
P value (p)*    NS NS      NS NS NS 
 
 NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test)  
 
Table 7: Water intake (ml/day) of Wistar albino rats group exposed to 
KARISALANKANNI CHOORANAM 
DOSE DAYS 
1 6 14 21 28 
CONTROL 60.1 ± 8.72 60±1.52 60.2±1.40 61±1.32 61.4±1.62 
LOW DOSE 65.1±1.21 65.6±4.22 66.6±1.02 65.2±2.06 66.4±1.20 
MID DOSE 62.1±1.02 62.3±1.21 62.1±2.62 63.4±4.32 63.4±1.64 
HIGH DOSE 64.1±1.81 64.2±1.32 64.4±1.14 64.6±1.62 65.8±2.02 













2 7 23 22 28 
CONTROL 34±4.14 34.2±6.12 34.3±2.18 34.2±1.14 34±5.62 
LOW 
DOSE 
36.3±1.64 36.3±1.51 36.2±1.51 36.5±1.62 36.5±1.22 
MID 
DOSE 
34.1±2.12 34.2±3.50 34.2±2.14 34.2±2.16 35.2±1.64 
HIGH 
DOSE 
32.4±1.62 32.1±1.64 32.6±2.36 32.6±1.20 36.4±2.32 
P value 
(p)* 

















13.4±0.71 13.30±0.14 13.4±0.13 13.72±0.13 N.S 
Total WBC  
(×103) 
09.41±0.22 09.32±0.22 09.34±0.22 09.30±1.10 N.S 
Neutrophils (%) 21.13±0.60 21.02±0.52 22.11±1.42 22.02±2.71 N.S 
lymphocyte (%) 82.10±1.26 82.12±1.42 83.10±2.44 83.20±2.54 N.S 
Monocyte (%) 1.1±0.03 1.1±0.01 1.2±0.04 1.1±0.03 N.S 
Eosinophil (%) 0.8±0.03 0.8±0.04 0.9±0.05 0.9±0.08 N.S 
Platelets 
cells103/µl 
900.17±3.18 902.11±4.62902.11±2.20902.22±2.64 N.S 
Total RBC 106/ µl 9.32±0.11 9.47±0.33 9.50±0.64 9.60±0.46 N.S 
PCV% 48.10±0.2 48.62±5.30 48.8±4.70 48.4±.71 N.S 
MCHC g/dL 36.5±1.61 36.2±1.51 36.8±1.30 36.13±1.60 N.S 




















(mg/dl) 138.10±2.02 138.12±2.10 138.9±12.06 138.12±5.25 N.S 
T.CHOLESTEROL(
mg/dl) 140.14±5.10 140.15±5.20 142.40±1.68 143.21±1.10 N.S 
TRIGLY(mg/dl) 74.15±1.82 74.11±1.32 74.15±1.22 76.16±1.21 N.S 
LDL 78.6±2.13 78.7±2.05 78.10±1.03 78.40±01.32 NS 
VLDL 14.2±1.52 14.20±2.41 14.02±1.32 14.04±12.15 NS 
HDL 28.12±4.32 28.32±2.50 28.46±1.20 28.51±1.23 NS 
Ratio 1(T.CHO/HDL) 3.73±1.16 3.72±1.80 3.73±1.32 3.74±2.33 NS 
Ratio 2(LDL/HDL) 1.92±1.22 1.92±1.20 1.93±2.20 1.94±06.02 NS 




















UREA (mg/dl) 14.50±0.29 14.50±0.29 14.46±1.18 14.42±1.22 N.S 
CREATININE(mg/dl) 0.42±0.02 0.41±0.04 0.43±0.03 0.44±0.09 N.S 
BUN(mg/dL) 19.1±0.02 19.10±0.34 19.6±0.42 19.26±1.02 NS 






























































































































MATERIAL AND METHODS  
Animals  
Albino rats  (Wistar  strain)  were  obtained  from C.L.Baid metha college of 
pharmacy,chennai  India. The rats  were  housed  in  an  animal  house  with 
temperature and humidity control. Water and rat pellets  (Biogen Bangalore 
Industries,  India)  were provided to the animals ad libitum. The animals were daily 
monitored  for  their  behaviour  and health.   
 
Acclimatization  
 Prior to any experimentation, the animals were allowed  to  adapt  to  the  
animal  house environment for 15 days. During this period, no experiments were 
performed on the animals. The males  and  females  were  separated  and  kept  in 
clean cages. Suitable temperature, humidity and lighting conditions were maintained 
and feed and water were supplied ad libitum. Cleanliness and hygienic conditions 
were maintained as required. The animals were monitored regularly for signs of 
infection or injury.   
 
Grouping of the animals  
The  acclimatized  animals  were  subsequently divided into five groups each 
consisting of five rats  (2  males  and  three  females)  and  tails/ears were  marked  
accordingly.  Group  I  constituted the  control  animals  that  were  not  induced  for 
anaemia  and  did  not  receive  any  treatment  for anaemia.  Anaemia  was  
experimentally  induced in animals of group II, group III and group IV. The  group  II  
animals  served  as  the  anaemic control  (negative  control)  animals  that  did  not 
receive any treatment with the test formulations. Group  III animals  received 
Karisalankanni Chooranam 100mg/kg and group IV received Karisalankanni Chooranam 
200mg/kg group IV animals received conventional  chemotherapy,  i.e.  allopathic 





Induction of anaemia  
Desferrioxamine  (Desferal,  Novartis, Switzerland),  a  chemically  treated  
form  of  ferrioxamine  was  used  as  an  iron  chelator  for induction of anaemia in 
Wistar rats. Based on  LD50  value  of  desferal,  1/10th  of  the  dose  was calculated  
and  accordingly,  15  mg  of  desferal powder dissolved  in  0.7  ml  of  injection  
grade distilled  water  (injection  grade,  pyrogen  free) was administered  in  the  rats  
via  intramuscular route  for  15  days.  During  this  period,  the  rats were fed wheat 
flour along with the feed.  The  animals  were  observed  for  any  toxicity symptoms,  
general  behaviour and body  weight. Hemoglobin content of group II rats (% Hb) was 






Hemoglobin level of Karisalankanni Chooranam 
 
S.no  Groups  Hemoglobin Hb (g/dl) 
1 Control 16.6±42.1 
2 Desferal Treated 10.5±21.5 
3 Desferal +Karisalankanni Chooranam 
100mg 
12.6±12.74 
4 Desferal + Karisalankanni Chooranam 
200mg 
14.8±10.22 










MATERIALS AND METHODS 
 
STUDY DESIGN: 
An open clinical trial on paandu noi was carried out in the OP of P.G 
Kuzhanthai Maruthuvam Department attached to Aringnar Anna Hospital of Indian 
Medicine, Chennai-106. 
The study was approved by Institutional Ethical Committee(IEC) and 
approval number is GSMC-CH-ME-2/01/20182017 
 
POPULATION AND SAMPLE:            
The population consists of all patients satisfying the inclusion and exclusion 
criteria mentioned below. Sample consists of paandu noi patients who were attending 
the OP of Aringnar Anna Hospital, Arumbakkam, Chennai- 106. 
 
SAMPLE SIZE: 
The study is considered in 40 selected patients of both genders between age 
groups of 3-12 years. 
 
INCLUSION CRITERIA: 
 Age: 3-12 years 
 Hb level between 7-12 gms 
 Worm infestation 
 Angular stomatitis 
 Pallor of the skin, mucous membrane, nail bed and conjunctiva. 




EXCLUSION CRITERIA:  
 Known H/O of Metabolic disorder  
 Known H/O of Haemolytic  anaemia    
 Patient with  previous blood transfusion 
 Patient with any other serious illness. 
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WITHDRAWAL CRITERIA:  
 Exacerbation of symptoms.  
 The subject develops adverse drug reactions and adverse event they will be 
withdrawn from the trial.  
 Patient turned unwilling to continue in the course of clinical trial. 
 
EVALUATION OF CLINICAL PARAMETERS:  
Patients are clinically evaluated by using the following parameters  
 
History taking:  
Age, occupation, Socio economic status, complaints and duration, past illness, 
family history, and  personal habits were recorded in the case sheets for every patients 
during his / her first visit to OP.  
 
INVESTIGATIONS:  
Blood : TC, DC, ESR, Hb  
Urine : Albumin, Sugar,Deposit  
 
SPECIFIC IVESTIGATIONS:  
Blood : PCV, MCV, MCH, MCHC, Total RBC  
Motion: Ova, Cyst, Occult blood  
 
CLINICAL DIAGNOSIS BASED ON SIDDHA SYSTEM:  
The parameters used to diagnose the disease paandu Noi in siddha system are 
as follows,  
 Poriyal aridhal  
 Pulanaal aridhal  
 Vinaadhal  
 Uyirthathukkal  





METHODOLOGY OF TREATMENT:  
Study Enrollment:  
 Patient reporting at the OPD associated with clinical features of Pallor in 
conjuctivia & mucous membrane, Headache, Fatigue, Loss of appetite, worm 
infestation, dyspnoea on exertion, constipation are chosen for enrolment based on the 
inclusion criteria. The patients who are enrolled are informed about the study trial 
drug Karisalankanni chooranam, possible outcomes and the objectives of the study in 
the language and terms understandable to them and then informed consent/assent 
would be obtained from the patient/patients parent using consent/Assent form.  
 
Conduct of the Study:  
 On the first day onwards the trial drug “Karisalankanni chooranam” (Internal) 
will be given. The trial drug will be given in the OPD department of Kuzhanthai 
Maruthuvam, GSMC, Chennai. The patients will be asked to have a regular follow up 
in the OPD department once in 7days. In each and every visit the clinical assessment 
will be recorded in the prescribed proforma.The laboratory investigation will be done 
before and after treatment and recorded in the prescribed format.  
 
Data collection forms:  
 Required information will be collected from each patient by using following 
forms.  
              Form I       : Screening and selection proforma.  
              Form II     : History taking proforma.  
              Form III    : Clinical assessment proforma.  
              Form IV    : Clinical assessment during and after trial.  
              Form V     : Laboratory Investigation proforma.  
              Form VI    : Informed consent/Assent form.  
              Form VII   : Withdrawal form.  





Data Analysis:   
 After enrolling the patients in the study, a separate file for each patient will be 
maintained and all forms will be kept in the file. Whenever the patient visits OPD 
during the study period, necessary entries will be made in the assessment forms.  
 The data entries and adverse events if any will be monitored by the Head of 
the Department.  
 
OUTCOME OF TREATMENT:  
Primary Outcome:  
 Primary outcome is mainly assessed by reduction in clinical symptoms and by 
Raising Hb above 3 g/dl and comparing the following parameters before and after 
treatment. 
Secondary Outcome:  
 Secondary outcome is assessed by comparing the safety parameters before and 
after treatment.  
 
Adverse Effect and Serious Effect Management:  
 If the trial patient develops any adverse reactions the patient will be referred to 
the Pharmacovigilance department of SCRI and documented. For any adverse effect 
the investigator will give the proper management in the OPD.  
 
ETHICAL ISSUES: 
1. Informed consent/Assent will be obtained from the patient/patient‟s parent or 
guardian after explaining about the clinical trial in an understandable 
language.  
2. After the consent/Assent of the patient or patient’s parent(through 
consent/Assent) if they fit in the criteria they will be enrolled in the study.  
3. Treatment will be provided free of cost.  
4. Concomitant medicines will be used if there is any need.  





RESULTS AND OBSERVATION: 
 
 A total number of 40 child patients with signs and symptoms of Paandu Noi 
attending P.G-IV, KuzhanthaiMaruthuvam, Out Patient Department in Govt. Siddha 
Medical College attached to Aringnar Anna Hospital during 2016- 2019 were 
observed in the present study. The observations were made and tabulated with regards 
to the following features:   
 
1. Age Distribution  
2. Gender Distribution  
3. Socio-Economic status  
4. Aetiological factor  
5. Dietary habits  
6. Seasonal reference  
7. Reference to Thinai  
8. UyirThathukkal  
9. Udarthathukkal  
10. Envagaithervugal  
11. Neikkuri  
12. Clinical prognosis  
13. Results after treatment  
 
The observation recorded are given below in tabular form 
 
  





























































































































































































































. Of Cases 
32 
8 

































































































































































































7. REFERENCE TO THINAI 
S. NO. NILAM NO. OF CASES PERCENTAGE 
1 Kurinji 0 0% 
2 Mullai 0 0% 
3 Marutham 0 0% 
4 Neithal 40 100% 





 Among the 40 cases reported were from the surroundings of Chennai which 














8. UYIR THATHUKKAL 
i. Vatham: 
 
S. NO. VAATHAM NO. OF CASES PERCENTAGE 
1 Praanan 40 100% 
2 Abaanan 26 65% 
3 Vyaanan 40 100% 
4 Udhaanan 40 100% 
5 Samaanan 40 100% 
6 Naagan 0 0% 
7 Koorman 0 0% 
8 Kirukaran 40 100% 
9 Dhevadhaththan 40 100% 




 In 40 cases, among 10 types of vaatham, praanan, viyaanan, udhaanan, 
samaanan, kirukaran and devathaththan were affected in all 40 cases (100%), abaanan 
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 The above table reveals that, among all the 40 cases Anorexia was reduced, 
pallor of conjunctivae, tongue nail beds was reduced in 30 cases among 40, fatigue 
was reduced in 36 cases  among 40, constipation was reduced in all cases, lack of 
interest / concentration was reduced in 14 cases among 20, angular stomatitis was 
reduced in 15 cases among 17. 
 
13. RESULTS AFTER TREATMENT 
                  Results were observed on the basis of two main criteria. One on tbe basis 
of clinical improvement and the other on the results derived from the blood picture.  
a. Results from  clinical improvement  
 Good, Moderate, Mild improvements were assessed on the basis of relieved 
signs and symptoms as follows.  
Good improvement 
 Anorexia – nil  
 Fatigue – nil  
 Pallor of conjunctiva and nail beds – nil  
 constipation – nil   
 Lack of interest / concentration – improved  
Moderate improvement  
 Anorexia – nil  
 Fatigue – nil  
 Pallor of conjunctiva and nail beds – improved  
 constipation – moderately improved   
 Lack of interest / concentration – slightly improved  
Mild improvement  
 Anorexia – nil  
 Fatigue – present or absent  
 Pallor of conjunctiva and nail beds – present  
 Constipation – present  
 Lack of interest / concentration – present  
 Among the 40 cases, 27 cases assessed as good improvement, 8 cases assessed 
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CASE SUMMARY OF THE PATIENTS: 
 
S.NO. OP NO. NAME AGE(YEARS)/SEX REMARKS 
1 9733 Melvin 10/mc Moderate 
2 750 Janani sridevi 7/fc Mild 
3 2724 Mitheshwaran 3/mc Moderate 
4 822 Vasanthi 7/fc Moderate 
5 797 Kagan 5/mc Mild 
6 2941 Aravindh 4/mc Moderate 
7 3637 Kousalya 5/fc Good 
8 3688 Logeshwaran 7/mc Moderate 
9 3079 Monika 8/fc Good 
10 494 Tharshini 3/fc Moderate 
11 493 Vignesh 8/mc Good 
12 1007 Tharshini 8/fc Good 
13 2959 Ketson 4/mc Good 
14 2958 Nithya 7/fc Good 
15 4937 Deniyal 7/mc Moderate 
16 4936 Mikayal 9/mc Good 
17 7575 Sundar 8/mc Good 
18 7318 Hariharan 10/mc Moderate 
19 5681 Monesh 11/mc Good 
20 8452 Nisha 12/fc Mild 
21 1638 Sandhiya 5/mc Good 
22 5191 Sakthi 4/fc Good 
23 2288 Rajesh 5/mc Mild 
24 2558 Roshan 3/mc Good 
25 1416 Sai krish 5/mc Mild 
26 3304 Oviyasri 3/fc Moderate 
27 8981 Aswin kumar 10/mc Moderate 
28 540 Elakkiya 8/fc Good 
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29 7576 Sam rakshan 6/mc Good 
30 5612 Nikkilesh 3/mc Mild 
31 613 Nikkitha 3/fc Mild 
32 2760 Joswa 4/fc Moderate 
33 4177 Shakila 6/fc Good 
34 4343 Abijith Krishna 5/mc Good 
35 5552 Sarika 12/fc Moderate 
36 7419 Yogeshwaran 12/mc Good 
37 2272 Hariharasudhan 7/mc Good 
38 3940 Hemala 7/fc Moderate 
39 3836 Manith 12/mc Good 




LABORATORY INVESTIGATION REPORT OF THE PATENTS 








DC BT AT BT AT 
P L E P L E 1/2 HR 1 HR 1/2 HR 1 HR Alb Sug Dep Alb Sug Dep 
1 9733 10/mc 6000 45 49 6 6500 47 51 2 7 18 7 14 N N N N N N 
2 750 7/fc 8100 51 42 7 8500 50 45 5 12 25 9 18 N N N N N N 
3 2724 3/mc 10700 64 32 4 10000 58 40 2 14 22 10 20 N N N N N N 
4 822 7/fc 7300 61 33 6 7600 55 40 5 9 21 7 14 N N N N N N 
5 797 5/mc 12500 77 17 6 12000 65 33 2 3 5 6 12 N N N N N N 
6 2941 4/mc 7200 52 43 5 8000 51 44 5 7 12 7 12 N N N N N N 
7 3637 5/fc 7800 56 34 10 7900 58 36 6 15 25 10 20 N N N N N N 
8 3688 7/mc 6800 43 48 9 7000 45 49 6 8 15 7 14 N N N N N N 
9 3079 8/fc 8200 52 42 6 8100 52 44 4 5 12 6 12 N N N N N N 
10 494 3/fc 11300 26 63 8 11200 40 45 5 10 26 8 16 N N N N N N 
11 493 8/mc 5300 72 28 6 6800 52 43 5 3 8 5 10 N N N N N N 
12 1007 8/fc 10600 58 36 6 9400 50 44 6 2 6 7 14 N N N N N N 
13 2959 4/mc 8900 45 47 8 8500 50 43 7 22 42 10 20 N N N N N N 
14 2958 7/fc 6000 56 39 5 7300 53 43 4 8 15 6 12 N N N N N N 
15 4937 7/mc 7500 48 45 7 8000 49 45 6 14 20 10 20 N N N N N N 
16 4936 9/mc 6800 73 24 3 6800 58 38 4 21 38 11 24 N N N N N N 
17 7575 8/mc 7200 64 30 6 7100 54 42 4 5 12 7 14 N N N N N N 
18 7318 10/mc 5300 45 49 6 6900 50 45 5 7 12 7 12 N N N N N N 
19 5681 11/mc 6100 45 49 6 7200 49 48 3 10 25 8 16 N N N N N N 
20 8452 12/fc 9500 68 26 6 8300 58 35 7 10 22 7 14 N N N N N N 
 BT- Before Treatment, AT- After Treatment, N-Nil, TC-Total Blood Count, DC-Differential Blood Count,P-Polymorphs, L-Leucocytes, 
EEosinophils, ESR-Erythocyte Sedimentation Rate, mm-Milimeter, Hb-Hemoglobin, Alb-Albumin, Sug-Sugar, Dep-Deposits.   
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S. NO. OP NO. AGE(YEARS)/ SEX 




DC BT AT BT AT 
P L E P L E ½ HR 1 Hr ½ Hr 1Hr Alb Sug Dep Alb Sug Dep 
21 1638 5/mc 5700 60 31 9 6500 54 40 6 9 20 5 10 N N N N N N 
22 5191 4/fc 7200 69 30 1 7200 60 36 4 5 11 11 22 N N N N N N 
23 2288 5/mc 5800 58 35 7 6300 55 40 5 7 15 9 18 N N N N N N 
24 2558 3/mc 8400 52 41 7 8100 54 42 4 4 10 7 14 N N N N N N 
25 1416 5/mc 11200 37 56 7 10800 48 45 7 2 10 5 10 N N N N N N 
26 3304 3/fc 7600 56 39 5 8000 53 42 5 5 15 10 20 N N N N N N 
27 8981 10/mc 7800 44 50 6 7500 48 46 6 10 25 7 16 N N N N N N 
28 540 8/fc 8600 47 46 7 9200 50 45 7 7 14 7 14 N N N N N N 
29 7576 6/mc 3500 53 38 9 5000 55 41 4 3 8 6 14 N N N N N N 
30 612 3/mc 7100 48 42 10 7600 50 43 7 14 22 11 22 N N N N N N 
31 613 3/fc 11900 50 43 7 10900 52 42 6 7 15 9 18 N N N N N N 
32 2760 4/fc 8400 47 47 6 8800 49 43 8 5 10 6 14 N N N N N N 
33 4177 6/fc 7700 53 42 5 8000 55 42 3 28 40 12 24 N N N N N N 
34 4343 5/mc 6800 54 42 4 7100 50 45 5 13 26 9 18 N N N N N N 
35 5552 12/fc 7200 58 38 4 8100 55 41 4 14 28 10 20 N N N N N N 
36 7419 12/mc 5400 43 48 9 6800 50 42 8 15 28 9 18 N N N N N N 
37 2272 7/mc 9800 52 42 6 9700 48 45 7 15 30 11 22 N N N N N N 
38 3940 7/fc 6600 50 40 10 7100 52 43 5 14 28 7 14 N N N N N N 
39 3836 12/mc 7200 49 45 6 7600 50 45 5 7 14 3 6 N N N N N N 
40 4810 10/fc 8900 53 43 4 8800 54 42 4 8 16 5 10 N N N N N N 
  
 BT- Before Treatment, AT- After Treatment, N-Nil, TC-Total Blood Count, DC-Differential Blood Count,P-Polymorphs, L-Leucocytes, 
EEosinophils, ESR-Erythocyte Sedimentation Rate, mm-Milimeter, Hb-Hemoglobin, Alb-Albumin, Sug-Sugar, Dep-Deposits.   
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BIO CHEMICAL AND HEMATOLOGICAL REPORTS 
S. NO. OP NO. NAME AGE(years)/ SEX Hb (gms/dl) RBC (Millions/dl) PCV (%) MCV (fl) MCH (Pg) MCHC (gm/dl)BT AT BT AT BT AT BT AT BT AT BT AT 
1 9733 Melvin 10/mc 11.5 13 3.4 3.6 36 40 70 75 26 29 32 34 
2 750 Janani sridevi 7/fc 11.5 13 3.5 3.8 35 36 85 88 27.5 30 32.4 35 
3 2724 Mitheshwaran 3/mc 10 12.5 3.1 3.3 30 35 72 76 22 25 30 34 
4 822 Vasanthi 7/fc 10.8 12.5 3.5 3.8 32 35 73 77 26 28 32 33 
5 797 Kagan 5/mc 11.6 12.8 3.3 3.7 30 34 72 76 23 25 31 33 
6 2941 Aravindh 4/mc 10.2 12 3.1 3.4 31 35 69.8 74 23 25 31 33 
7 3637 Kousalya 5/fc 9.7 11.8 3.2 3.8 32 33 72.3 73.5 22.2 23 30.8 32 
8 3688 Logeshwaran 7/mc 11.1 12.8 3.7 3.9 32 34 72 80 26 38 32 33 
9 3079 Monika 8/fc 9.3 12.6 3.4 3.6 34 35 76 80 26 38 32 33 
10 494 Tharshini 3/fc 9.9 12.6 4 4.2 22 25 73 86 24 26 27 33 
11 493 Vignesh 8/mc 9 12.8 3.2 3.4 29 31 69 78 23 27 28 33 
12 1007 Tharshini 8/fc 8.6 11.9 2.8 3.2 17 20 68 80 27 30 28 34 
13 2959 Ketson 4/mc 8 11 3.2 3.7 21 23.2 75 85 27 32 31.2 33 
14 2958 Nithya 7/fc 10.5 13.6 3.4 3.6 28 32 70 83 23 27 24 29 
15 4937 Deniyal 7/mc 11 12.7 4 4.2 32 34 72.3 78 22.2 25 30.8 32 
16 4936 Mikayal 9/mc 10.7 13.8 3.2 3.3 32 34 71 87 22 29 32 34 
17 7575 Sundar 8/mc 10.2 13.3 3.2 3.4 23 30 51.3 69 26.6 29 22.1 30 
18 7318 Hariharan 10/mc 11.6 13.4 3.6 3.8 37 37 80 82 26.9 28 33.7 35 
19 5681 Monesh 11/mc 10.8 13.9 3.6 3.6 40 42 82.3 85 26.3 30 32 34 
20 8452 Nisha 12/fc 11 12.2 3.5 3.8 32 35 76 90 24 27 32 34 
  
 BT- Before Treatment, AT- After Treatment, PCV-Packed Cell Volume, MCV-Mean Corpuscular Volume, RBC-Red Blood Cells  MCH-Mean 
Corpuscular Hemoglobin, MCHC- Mean Corpuscular Hemoglobin Concentration.
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S.NO. OP NO. NAME AGE(years)/SEX 
HB(GMS/DL) RBC(MILLIONS/DL) PCV (%) MCV (fl) MCH (Pg) MCHC (gm/dl)
BT AT BT AT BT AT BT AT BT AT BT AT 
21 1638 Sandhiya 5/fc 8.6 11.8 3.4 3.3 34 38 74 89 25 28 32 35 
22 5191 Sakthi 4/fc 7.7 10.8 3.9 3.9 25 30 55 68 17 25 30.6 34 
23 2288 Rajesh 5/mc 11.6 12.9 2.8 3.3 36 40 85 88 26 29 32 33 
24 2558 Roshan 3/mc 8.4 11.5 3.5 3.9 25 29 57 71 17 22 29.7 33 
25 1416 Sai krish 5/mc 11.4 12.6 3.7 3.9 34 36 78 80 24.5 28 31.6 34 
26 3304 Oviyasri 3/fc 10 12.3 3.3 3 35 38 77 82 26 30 33.8 34 
27 8981 Aswin kumar 10/mc 11.5 12.7 3.5 3.9 35 38 81 84 26.6 30 33 36 
28 540 Elakkiya 8/fc 10 13.2 3.3 3.5 35 40 80 84 26 32 32.5 34 
29 7576 Sam rakshan 6/mc 6.5 9.6 3.1 3.3 28 34 75 88 24.2 28 32 34 
30 5612 Nikkilesh 3/mc 11.6 12.4 3.6 3.4 37 42 82 86 25.5 30 31.2 32 
31 613 Nikkitha 3/fc 11.8 12.7 3.7 3.8 37 41.2 78 80.4 23.7 26 31.4 33 
32 2760 Joswa 4/fc 11.1 13.5 3.4 3.5 20 26 72 83 30 34 28.3 33 
33 4177 Shakila 6/fc 10.8 13.9 3.7 3.7 20 27 68 82 28 32 31.5 34 
34 4343 Abijith krishna 5/mc 8.2 11.3 3.2 3.7 26 34 71 83 28 29 27 29 
35 5552 Sarika 12/fc 9.3 12.4 2.9 3.2 28 32 70 81 28 30 22 25 
36 7419 Yogeshwaran 12/mc 7.8 10.9 3.2 3.4 23 28 73 88 23.2 28 27 30 
37 2272 Hariharasudhan 7/mc 10 13.2 3.5 3.8 28 32 63 77 25 29 28.5 31.5 
38 3940 Hemala 7/fc 9.9 12.8 3.2 3.5 22 25 71 79 24 31 27.2 30.2 
39 3836 Manith 12/mc 9.8 12.9 3.8 3.8 20 24 70 80 30.2 33 29 32.5 
40 4810 Sagana 10/fc 8.8 12 3 3.4 30 32 72 87 30 34 32 33 
  
BT- Before Treatment, AT- After Treatment, PCV-Packed Cell Volume, MCV-Mean Corpuscular Volume, RBC-Red Blood Cells  MCH-Mean 





PaanduNoi is a clinical entity described by Siddhars and having symptoms 
such as loss of appetite, lassitude, pallor of skin and mucous membrane, conjunctivae, 
tongue, and nail beds, angular stomatitis. These symptoms are identical with Iron 
Deficiency Anaemia (Microcytic hypochromic anaemia) a clinical entity described in 
modern medical literature.  
Iron deficiency anaemia is one of the most common and widespread nutritional 
disorder present throughout the world and its prevalence is higher in children, but they 
are not completely relieved from their symptoms by other system of medicine. Hence 
with the help of trial medicine from Siddha system, results and observation are noted 
for the study.  
The patients were examined based on Siddha as well as modern aspects.  
All the necessary investigation were made during the study. The results 
obtained from their studies were discussed below for better conclusion.  
Trial medicine administered was Karisalankannichooranam 200- 500mg with 
honey, 2 times a day after food for 28 days.   
In this study, 40 cases were selected according to the proforma with 
investigations and treated with the trial drug Karisalankannichooranam for 28days.  
The treatment and investigation was done in the OPD of PG-Dept. of 
KuzhanthaiMaruthuvam, Govt.Siddha Medical College attached to Arignar Anna 
Hospital of Indian Medicine Chennai-106, during the period 2017-2019. All the 
necessary investigations were carried out to all patients and trial drug were given. 
Weekly follow up were done. All the patients were strictly advised to follow diet and 
peaceful lifestyle to normalize the immune mechanism.  
Drug Authetication : 
All the ingredients of the trial drug Karisalankannichooranamwere procured 
from indigenous drug shop, Park town, Chennai. 
Microscopic and Macroscopic examination was conducted, identified  and 
authenticated by the concerned pharmacognosist,GSMC, Chennai.  
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Pre clinical screenings:  
Biochemical Analysis:  
Qualitative Analysis of the trial drug revealed the presence of  iron, chloride, 
calcium, starch, reducing sugar.  
Phytochemical Analysis:  
The phytochemical analysis of the trial drug shows that the drug contains 
Glycosides, Carbohydrates, Coumarins, Phenols.  
Physico chemical Analysis:  
Loss on drying at 105
0
C - 2.43%  
Total ash     - 17.6%  
PH        - 5 
Acid insoluble ash  - 0.26% 
Water soluble extractive  -26% 
Alcohol soluble extractive - 12% 
TOXICITY STUDY OF THE DRUG:   
IAEC NO: LV/11/CLBMCP/2018 
Acute toxicity:  
               Acute and sub acute toxicity studies were conducted on experimental rats at 
C.L.BaidMetha College of Pharmacy, Chennai, Tamilnadu.  
               Acute toxicity study of the drug k was carried out as the OECD guideline-
423 (Organisation to Econamic Co-operation and Development).  
                The acute toxicity study of  my trial drug was studied and the drug was 
proved safer for long term administration, as it did not exhibit any significant toxicity 





Sub acute toxicity:  
Sub acute toxicity study as per the guideline of – 407. Under the dosage of trial drug 
200mg / kg (Low dose), 400mg / kg (High dose) it did not exhibit any significant.   
Histo pathology:  
                 At the end of toxicity studies the animal were sacrified and they were 
subjected to hematological parameters (TC, DC &Hb) chemical parameters ( LFT, 
RFT) and histopathology of vital organs like Liver, Kidney, Spleen, Lungs were 
carried out. The studied did not exhibit the evidence of remarkable pathological 
lesions in the tissues.  
Pharmacological activity:  
The pharmacological studies of trial medicine Karisalankannichooranam 
showed significant Haematinic action wistar albino rats.  
Haematinic action of Karisalankannichooranamwas carried out by producing 
anemia by administrating a single intramuscular injection ofdesferrioxamine at a dose 
of 15mg/kg b.w. Drop out period of four days was awaited until the sufficient drop in 
Hb level was noticed in animals. Rats were considered as anaemic model if 
haemoglobin concentration was less than 14g/dl. Then the trial drug was administered 
show a potent haematinic action during the studies.    
The result of preclinical screening, the result of chemical analysis, 
Toxicological studies, Pharmacological studies were shown in pre-clinical.  
Age Distribution:   
Among the 40 cases, 25% of patients were in the age group of  3to 5 years, 
20% were in the age group of 5 to 7 years, 32.5% were in the age group of 7 to 10 
years and 22.5% were in the age group of 10 to 12 years.  
Sex Distribution:  
Among the 40 cases for this present study, 21 (52.5%) children were male and 
19 (47.5%) children were female. According to modern theory there is no apparent 




Socio Economic status:  
Among the 40 cases, maximum numbers of patients 57.50% were in poor 
status, 32.50% were in middle class and 10% were in rich class. The highest incidence 
was observed in poor class children due to low nutritional diet, so the poor children 
are more prone to the disease.   
Aetiological factor:  
Among 40 cases, 20% cases were due to worm infestation, 80% cases were 
due to nutrional deficiency because of poor intake of food respectively.  
Dietary Habits : 
Among 40 cases was reported, 65% belonged to mixed diet and 35% belonged 
to vegetarian diet habit respectively.  
According to Paruvakaalam:  
Regarding Paruvakaalam among 40 cases, 5% cases were reported in 
Kaarkaalam, 5% cases were reported in Koothirkaalam, 7.5% cases were reported in 
ElavenilKaalam, 50% cases were reported in Munpanikaalam, 32.5% cases were 
reported in Pinpanikaalam and no cases were reported in Muduvenilkaalam 
respectively  
Thinai:  
Among the 40 cases reported were from surroundings of Chennai which 
belongs to Neithalnilam.It cause increase in pitham. 
UyirThathukkal:  
Disturbance of Vatham : 
 In 40 cases, among 10 types of Vaatham, Praanan was affected in a 100% of 
cases because of dyspnoea on exertion, Abanan was affected in a 65% of cases due to 
constipation, Viyaanan was affected in a 100% of cases because of pallor of skin, 
Samaanan and Kirukaran were affected in a 100% of cases due to loss of appetite, 




Disturbance of Pitham: 
          Among 5 types of Pitham, except Aalosagam all types of pitham were affected. 
Sathagam was affected due to inability to do work, Ranjagam was affected which 
causes discolouration of blood, Anal pitham which causes loss of appetite, Prasagam 
was affected because of pallor of skin respectively.  
Disturbance of Kabam: 
Among 40 cases, Aavalamgam was affected in 40 cases(100%) due to dyspnea 
and Kilathagam was affected in 40 cases (100%) due to loss of appetite respectively.  
UdalKattukal:  
In this, Saaram and Senneer were affected in 100% of the cases. Saaram was 
affected because of anorexia, Senneer was affected because of pallor of skin.  
EnnvagaiThervugal: 
Among the Ennvagaithervukal, Naa, Niram and Vizhi were affected in all 
cases (100%). In 26 cases (65%) Malam, and in Naadi 20 cases (50%) Pithavaatham, 
in 9 cases (22.5%) vathakabam and in 12 cases (27.5%) Kabapitham were seen. 
Neikuri : 
Among 40 cases, Pithaneer was observed in 55% cases, vathaneer was 
observed in 20% cases, Kabaneer was observed in 25% cases.  
Clinical presentation:  
Out of 40 patients, before treatment all the 40 patients had 100% of pallor of 
conjunctivae, tongue, nail beds, Anorexia, fatigue, 65% of cases had constipation, 
50% of cases had Lack of interest and concentration, 43% of cases had angular 
stomatitis. After treatment most of the patients were relieved from the symptoms of 
anorexia and constipation. Pallor of conjunctivae, tongue, nail buds was present in 
25%, fatigue in 10%, lack of interest and dyspnoea on excertion  in 15%, angular 




Lab investigation:  
 Routine blood and urine examination were done before and after the treatment. 
In most of the cases, Total RBC count, PCV, MCV, MCH, MCHC were observed to 
be reduced. After treatment there is a tremendous increase in the haemoglobin level, 
Total RBC count, PCV,MCV,MCH, MCHC.  
 Haemoglobin range was Good (50%) in 20 cases, Moderate (32.5%) in 13 
cases, Poor (17.5%) in 7 cases in prognosis.  
Bio statistical study:   
 By statistical analysis, since the p value is significant in Hb level i.e., null 
hypothesis is rejected and alternate hypothesis is accepted.And  by age wise analysis, 
the mean difference is high in 8 years children and by sex wise analysis, the mean 
difference is high in male children. Thus concluding that there is differencein the 
means of before and after treatment. 
Result observed from Hb level:  
 Since the p value is significant (0.04). So the treatment was significantly 
improving the Hb level among the patients for the treatment of PaanduNoi.  
Treatment:  
In this study all 40 cases were treated with Karisalankannichooranam. The trial 
medicine having the properties of neutralizing pitham was given to the patients to set 
right the deranged pitham on the basis of Arusuvai and Panchabootham.  
So the selected trial drug is in the form of powder, is found to be normalize the 
increased pitham. Intake of powder with honey in therapeutic doses increase appetite 
and gives relief from abdominal discomfort and constipation.    
The trial medicine contain iron in the form of ferrous state that are easily 
absorbed. The efficacy was established throughout the treatment. During the treatment 








To study the efficacy of Siddha trail drug Karisalankanni chooranam as 
internal medicine for the treatment of PaanduNoi in children.This disease mostly 
resembles Iron deficiency anaemia in modern system. Literature evidences of both 
Siddha and Modern system were collected and also the ingredients of the trial drug 
was reviewed as well. For the clinical study, 40 patients were selected based on 
protocol. This study is conducted after the drug being screened by the Screening 
committee and approved by the Institutional Ethical Committee (IEC) of Govt. siddha 
medical college Chennai.  
Selected patients with PaanduNoi diagnosed clinically treated in outpatient 
department of Govt. siddha medical college attached with Arignar Anna Hospital of 
Indian Medicine, Chennai-106. They were undergone laboratory investigation and 
treated with trial drug, observed for clinical improvement and any adverse reaction.  
Qualitative analysis of the Karisalankanni chooranam presence of  iron, 
calcium, starch, chloride and Reducing sugar. Phytochemical analysis of the trial drug 
shows that presence of Glycosides, carbohydrates, coumarins, phenol.   
Physico chemical analysis of the trail drug shows the pH 5, Total ash value 
17.6% shows the safe and effectiveness of the trial drug. 
Toxicological studies shows that, it has no significant toxic effect. From the 
preclinical pharmacological study shows that the drug has got a significant haematinic 
activity. 
Among the 40 patient’s good improvement was observed in 20 cases (50%), 












Paandunoi is mainly caused by the derangement of Pithamfollowed by vatham 
and kabam. The deranged kuttram is settled down by the kaippusuvai in the trial drug 
there by medicine act effective in cure the disease.  
In physico chemical Analysis iron was found to be present as effective 
ingredients in treating anaemia.  
The Karisalankannichooranam reveal no toxicity in the preclinical studies and 
hence proven to be safe for human administration. 
From the pre- clinical pharmacological study it is evident that the trial 
medicine has significant Haematinic action.  
Also Karisalankannichooranam has been proved clinically. Since as it raises 
the haemoglobin level in a marked level to the patients given regularly for not less 
than 30 days along with supplementary diets. Both symptomatic and qualitative 
improvement were absorbed. For prognosis, routine haematological investigation was 
taken. During the treatment no adverse events were observed.  
Statistically it has been proved that it shows significant raise in the 
haemoglobin level.  
Hence I concluded that the trial drug Karisalankannichooranam will be a better 






















BIO STATISTICAL ANALYSIS 
AGE BEFORE AFTER DIFFERENCE 
11/Fc 11.5 12 0.5 
10/Fc 10.3 12.2 1.9 
08/Mc 11.5 11.8 0.3 
06/Mc 11.1 11.5 0.4 
09/Mc 9.2 10.5 1.3 
08/Fc 12 11.5 -0.5 
08/Fc 12.9 12.5 -0.4 
12/Fc 11.7 11.9 0.2 
09/Fc 10.4 11.2 0.8 
10/Fc 11.6 12 0.4 
12/Fc  9.9 11 1.1 
08/Fc 7.1 10.2 3.1 
61/2 /Fc 12.1 12.5 0.4 
08/Fc 13.1 12.8 -0.3 
07/Fc 12.4 12.1 -0.3 
09/Mc 12.9 12.8 -0.1 
08/Mc 8.6 10.2 1.6 
06/Fc 8.8 10.8 2 
06/Mc 13.4 13.4 0 
09/Fc 11.9 12 0.1 
06/Fc 12.1 12 -0.1 
07/Fc 8 10.2 2.2 
11/Mc 13.1 13.2 0.1 
06/Mc 12.2 12.4 0.2 
08/Mc 12.3 12.5 0.2 
08/Mc 12.2 12.8 0.6 
10/Fc 14.3 14 -0.3 
07/Fc 12.4 12.6 0.2 
61/2/Mc 13.4 13 -0.4 
12/Fc 12.7 12.6 -0.1 
06/Mc 11.3 11.2 -0.1 
12/Mc 11.8 11.5 -0.3 
08/Fc 11.6 11.2 -0.4 
81/2/Mc 13 15 2 
06/Mc 11.2 12 0.8 
10/Mc 12 12.4 0.4 
07/Fc 9 10.2 1.2 
11/Fc 11.2 12 0.8 
08/Fc 11.8 12.2 0.4 
08/Fc 12 12.5 0.5 
MEAN 11.5 12.01 0.51 
St.dev 1.579841 1.035473 0.840269 
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 Mean value of HB before treatment: 11.5 ± 1.57 
 Mean value of Hb after treatment 12.01 ± 1.03 
To analyse the significance, Paired T- Test is chosen 
Results: 
T- Test of Paired sample 
  Variable 1 Variable 2 
Mean 11.5 12.01 
Variance 2.495897436 1.072205128 
Observations 40 40 
Pooled Variance 1.784051282   
Hypothesized Mean Difference 0   
df 78   
t Stat -1.707581759   
P(T<=t) one-tail 0.045845808   
t Critical one-tail 1.664624645   
 
 Null Hypothesis: There is no difference between means 
 Alternate Hypothesis: There is absolute difference between two means 
P- Value= 0.04 
 If the P-Value is less than 0.05, then the null hypothesis is rejected 
 As the P-Value of this study is 0.04, Null Hypothesis is rejected and Alternate 
hypothesis is accepted. Thus concluding that there is difference in the means of 
before and after treatment. 
 To signify the difference, Pearson correlation between two variables taken which 





coefficient of Correlation 
Value of r Strength of relationship 
-1.0 to -0.5 or 1.0 to 0.5 Strong 
-0.5 to -0.3 or 0.3 to 0.5 Moderate 
-0.3 to -0.1 or 0.1 to 0.3 Weak 
-0.1 to 0.1 None or very weak 
 
 As the r value of this study is 0.87, it shows that the result has Strong Positive 
correlation  
 i.e statistical correlation is measured by what is called the coefficient of 
correlation (r). Its numerical value ranges from +1.0 to -1.0. It gives us an 
indication of both the strength and direction of the relationship between variables. 
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN 
MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “KARISALANKANNI CHOORANAM” IN THE 
TREATMENT OF “PAANDU NOI” (IRON DEFICIENCY ANAEMIA) 
IN CHILDREN 
FORM l - SCREENING AND SELECTION PROFORMA 
1. OP NO   : ……………………….. 
2. NAME  : ……………………….. 
3. AGE    : ……………………….. 
4. GENDER   :……………………….. 
5. F.OCCUPATION  :……………………….. 
6. F.INCOME  : ……………………….. 
7. ADDRESS  : ……………………….. 
8. CONTACT NO : ……………………….. 
 INCLUSION CRITERIA:  
 Age :  3-12 Yrs        Yes/ No  
 Hb 7-11 gm        Yes/ No  
 Patient having sign of pallor in conjunctivae, tongue, Nail bud Yes/ No    
 Patient having symptoms of fatigue , Anorexia, dyspnoea on exertionYes / No               
 Loss of memory/ lack of concentration    Yes/ No  
 Patient suffering from worm infestation    Yes/ No  
 Patients who are willing to undergo laboratory investigation. Yes/No  
 Patients who are willing to sign the informed consent stating that she will 
continuously stick to the treatment during 28days but can opt out of the trial of 




EXCLUSION CRITERIA  
(Clinical history)  
 History of Metabolic disorder  
 History of Haemolytic anaemia  
 Patient with  previous blood transfusion 
 Patient with any other serious illness  
 
ADMITTED TO TRIAL:  
 
 YES                        NO                  
 
If yes,                       OPD/IPD                     
 
Date :         
Station :  
 
 






GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN 
MEDICINE, CHENNAI – 600 106 
CLINICAL STUDY ON “KARISALANKANNI CHOORANAM” IN THE 
TREATMENT OF “PANNDU NOI” (IRON DEFICIENCY ANAEMA) IN 
CHILDREN 
FORM II -HISTORY TAKING PROFORMA 
1. S. NO. OF THE CASE  : ……………………….. 
2. OP/IP NO    : ……………………….. 
3. NAME    : ……………………….. 
4. AGE     : ……………………….. 
5. GENDER    : ……………………….. 
6. F.OCCUPATION   : ……………………….. 
7. F. INCOME    : ……………………….. 
8. COMPLAINTS& DURATION : ……………………….. 
9. PERSONAL HISTORY  : ……………………….. 
10. HISTORY OF PREVIOUS ILLNESS: ……………………….. 
11. BIRTH HISTORY   : ……………………….. 
12. DIETARY HABIT   : 
• Vegetarian  
• Non-vegetarian  
13. FAMILY HISTORY   :                 
Whether this problem runs in family?   
 1. Yes                               2.No        
 If yes, mention the relationship of affected person(s) 
_________________________ History of previous investigations if any 
__________________________  
 
Date :         
Station : 
 
Signature of the Guide                              Signature of the Investigator 
 
 
GOVERNMENT SDIDHA MEDICAL COLLEGE ARIGNAR ANNA 
GOVERNMENT HOSPITAL OF INDIAN MEDICINE  
CHENNAI – 600 106  
CLINICAL STUDY ON “KARISALANKANNI CHOORANAM” IN THE 
TREATMENT OF 
“PAANDU NOI” (IRON DEFICIENCY ANAEMIA)IN CHILDREN 
 
FORM III ASSESSMENT PROFORMA 
 
1. SERIAL NO : ____________________ 
2. OP / IP NO : ____________________ 
3. NAME :____________________ 
4. AGE  : ____________________ 
5. GENDER : ____________________ 
GENERAL EXAMINATION:  
Height (cms)  : ____________________ 
Weight (kg)  : ____________________ 
Temperature(°F)  : ____________________ 
Pulse rate(/min)  : ____________________ 
Heart rate(/min)  :____________________ 
Respiratory rate(/min) : ____________________ 
Blood pressure(mm/Hg) :____________________ 
 
Present           Absent  










SYSTEMIC EXAMINATION  
CardioVascularSystem   : ____________________ 
Respiratory system  : ____________________ 
Gastro-intestinal system : ____________________ 
Central Nervous System : ____________________ 
Urogenital system : ____________________ 
Endocrine System : ____________________ 
SIDDHA SYSTEM OF EXAMINATIONS:  
I. THEGI:  [BODY CONSTITUTION]   
i. Vathaudal : 
ii. Pithaudal : 
iii. Kabaudal : 
iv. Thonthaudal :  
II. NILAM:  [LAND WHERE PATIENT LIVED MOST]  
a) Kurinji(Hilly terrain) : 
b) Mullai(Forest range) : 
c) Marutham(Plains) : 
d) Neithal(Coastal belt) : 
e) Paalai (Arid regions) : 
III. KAALAM:  
a. Kaarkaalam  : 
b. Pinpanikaalam : 
c. Koothirkaalam : 
d. Ilavenilkaalam : 
e. Munpanikaalam : 
f. Muthuvenilkaalam : 
IV. GUNAM: 
1. Sathuvam : 
2. Raasatham : 




V. IMPORIGAL (SENSORY ORGANS):  
Normal/Affected  
Mei  :____________________ 
Vaai  :____________________ 
Kann  :____________________ 
Mookku :____________________ 
Sevi  :____________________ 
 
VI. KANMENDHIRIYAM (MOTOR ORGANS):  
Kai  : ____________________ 
Kal  :____________________ 
Vaai  :____________________ 
Eruvai  :____________________ 
Karuvaai :____________________ 
VII. KOSANGAL (SHEATH):  
Annamayakosam : ____________________ 
Pranamayakosam :____________________ 
Manomayakosam :____________________ 
Vignanamayakosam : ____________________ 
Anandamayakosam :____________________ 
VIII. UYIR THAATHUKKAL: [THREE HUMORS] (VALI, AZHAL, IYAM)  
A. VALI   
Praanan  : ____________________ 
Abaanan  : ____________________ 
Samaanan  :____________________     
Uthaanan  :____________________ 
Vyaanan  :____________________      
Naagan  :____________________ 
Koorman  :____________________ 
Kirukaran  :____________________ 
Devathaththan :____________________ 




B. AZHAL  
Analakam :____________________ 
Ranjakam : ____________________ 
Sathakam :____________________ 
Prasakam : ____________________ 
Alosakam : ____________________ 





Santhigam : ____________________ 
IX. SEVEN UDAL THATHUKKAL: (SEVEN SOMATIC COMPONENTS)  
Saram  : ____________________ 
Senneer : ____________________ 
Oon  : ____________________ 
Koluppu :____________________ 
Enbu  :____________________ 
Moolai  :____________________ 
Sronitham :____________________ 
X. ENVAGAI THERVU:  
1. NAADI : [PULSE PERCEPTION]          
2. SPARISAM : [PALPATION]  
3. NAA  : [TONGUE]   




5. MOZHI : [VOICE]  
i. High Pitched              
ii. Low Pitched  
iii. Medium Pitched  
6. VIZHI  : [EYES]  
 
 




           Others  










Date :       
Station :  
 
 







GOVERNMENT SIDDHA MEDICAL COLLEGE ARIGNAR ANNA 
GOVERNMENT HOSPITAL OF INDIAN MEDICINE  
CHENNAI – 600 106  
POST- GRADUATE DEPARTMENT OF KUZHANTHAI 
MARUTHUVAM 
 
CLINICAL STUDY ON “KARISALANKANNI CHOORANAM” IN THE 
TREATMENT OF “PAANDU NOI” (IRON DEFICIENCY 
ANAEMIA)IN CHILDREN 
 
FORM IV:  LABORATORY INVESTIGATIONS PROFORMA 
1. SERIAL NO. OF THE CASE : 
2. OP / IP NO   : 
3. NAME   :   
4. AGE    : 
5. GENDER   : 
 
A) BLOOD INVESTIGATIONS: 
BLOOD 
INVESTIGATIONS BEFORE TREATMENT 
AFTER 
TREATMENT 
Hb(gms/dl)   
T.RBC (million cells/ 
Cu.mm)   
ESR(mm) ½ hour   
 1 hour   
T. WBC (cells/cu.mm)   
Differential count(%) 
Polymorphs   
Lymphocytes   
Monocytes   
Esinophils   





BLOOD INVESTIGATIONS BEFORE TREATMENT AFTER TREATMENT 
PCV   
MCV   
MCH   
MCHC   
SERUM IRON   
SERUM FERRITIN   
TIBC   
 
 
INVESTIGATIONS BEFORE TREATMENT AFTER TREATMENT 
MOTION 
TEST 
OVA    
CYST   
 
B) URINE INVESTIGATIONS: 




Albumin   
Sugar   
Deposit   
 
Date :           
Station :  
 




GOVERNMENT SIDDHA MEDICAL COLLEGE ARIGNAR ANNA 
GOVERNMENT HOSPITAL OF INDIAN MEDICINE  
CHENNAI – 600 106  
CLINICAL STUDY ON “KARISALANKANNI CHOORANAM” IN THE 
TREATMENT OF “PAANDU NOI” (IRON DEFICIENCY 
ANAEMIA)IN CHILDREN 
 
FORM V: INFORMED CONSENT FORM 
 
“I have read the foregoing information, or it has been read to me. I have the 
opportunity to ask questions about it to my satisfaction.  
I consent voluntarily to participate my child in this study and understand that I 
have the right to withdraw my child from the study at any time without in any way it 
affecting my child further medical care”.  
"I have received a copy of the information sheet/consent form".  
Date:  
Signature of the participant:  
In case of illiterate participant  
“I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has the opportunity to ask questions. I confirm that the 
individual has given consent freely.”                                                    
Date:  
Signature of a witness                                    Left thumb Impression of the Participant      
(Selected by the participant bearing no connection with the survey team)        
Date :     
Station : 
Signature of participant:                                                  
 




அரசுசி த்தமருத்துவக்கல்லூரி , சென்னை-106 
அறி ஞர் அண்ணா  மருத்துவமனை, சென்னை 
பாண்டு நோய்க்கான சி த்த மருந்தி ன் (கரி சலங்கண்ணி  சூரணம்) பரி கரி ப்புத் 
தி றனைக் கண்டறி யும் மருத்துவ ஆய்வி ற்கான தகவல் படி வம் ஒப்புதல் படி வம் 
ஆய்வாளரால் சான்றளி க்கப்பட்டது. 
நான் இந்த ஆய்வை குறி த்த அனைத்து வி பரங்களையும் நோயாளி க்கு புரி யும் 
வகையி ல் எடுத்துர ைத்தேன் என உறுதி யளி க்கி றேன். 
தேதி  :                                                                         
கையொப்பம் : 
இடம் :                                                          பெயர் : 
நோயாளி யி ன் பெற்றோர் ஒப்புதல் படி வம் 
 என்னி டம் இந்த மருத்துவ ஆய்வி ன் காரணத்தையும், மருந்தி ன் தன்மை 
மற்றும் மருத்துவ வழி முறை பற்றி யும், தொடர்ந்து எனது உடல் இயக்கத்தை 
கண்காணி க்கவும்,  அதனை பாதுகாக்கவும் பயன்படும் மருத்துவ ஆய்வுக் கூட 
பரி ச ோதனைகள் பற்றி  தி ருப்தி  அளி க்கும் வகையி ல் ஆய்வு மருத்துவரால் 
வி ளக்கி க் கூறப்பட்டது. 
 நான் எனது குழந்தையி ன் இந்த மருத்துவ ஆய்வி ன் ப ோது காரணம் 
எதுவும் கூறாமல், எப்ப ொழுது வேண்டுமானாலு ம் இந்த ஆய்வி லி ருந்து எனது 
குழந்தையை வி டுவி த்து கொள்ளு ம் உரிமையை தெரி ந்தி ருக்கி றேன். நான் 
என்னு டைய சுதந்தி ரமாக தேர்வு செய்யும் உரிமையைக் கொண்டு நோய்க்கான 
கரி சலா ங்கண்ணி  சூரணம் மருந்தி ன் பரி கரி ப்புதி றனைக் கண்டறி யும் மருத்துவ 
ஆய்வி ற்கு என் குழந்தையை உட்படுத்த ஒப்புதல் அளி க்கி றேன். 
தேதி  :       கையொப்பம் : 
இடம் :                  பெயர் : 
                                                         
தேதி  :                                சாட்சி க்காரர் கையொப்பம் : 








GOVERNMENT SIDDHA MEDICAL COLLEGE, CHENNAI 
CLINICAL STUDY ON “KARISALANKANNI CHOORANAM” IN THE 
TREATMENT OF“PAANDU NOI” (IRON DEFICIENCY ANAEMIA) 
IN CHILDREN 
FORM VI - WITHDRAWAL FORM 
S. NO       :  
OP / IP NO      :                                                
NAME      :  
AGE / GENDER     :  
DATE OF TRIAL COMMENCEMENT  :  
DATE OF WITHDRAWAL FROM TRIAL :  
REASONS FOR WITHDRAWAL    
 Long absence at reporting     : Yes/ No  
 Irregular treatment     : Yes/ No  
 Shift of locality      : Yes/No  
 Increase in severity of symptoms   : Yes/No  
 Development of severe adverse drug reactions : Yes/No  
 
 
Date :           
Station :  
 





GOVERNMENT SIDDHA MEDICAL COLLEGE ARIGNAR ANNA 
GOVERNMENT HOSPITAL OF INDIAN MEDICINE  
CHENNAI – 600 106 
CLINICAL STUDY ON “KARISALANKANNI CHOORANAM” IN THE 
TREATMENT OF “PAANDU NOI” (IRON DEFICIENCY ANAEMIA) 
IN CHILDREN  
FORM VII – PATIENT INFORMATION SHEET 
Name of Co- Investigator:  K. Karpagavalli 
Name of the college:  Govt. Siddha Medical College, Arumbakkam, Chennai-106.  
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL.  
I, K. Karpagavalli, studying M.D(Siddha) at Govt.Siddha Medical College, 
Chennai, is doing a clinical trial on “PaanduNoi” –Iron Deficiency Anaemia in 
children. It is becoming a most common disease, occurring throughout the world. In 
this regard, I am in need to ask you few questions. I will maintain confidentiality of 
your comments and data obtained. There will be no risk of disclosing your identity 
and no physical, psychological or professional risk is involved by taking part in this 
study. Taking part in this study is voluntary. No compensation will be paid to you for 
taking part in this study.   
You can choose not to take part. You can choose not to answer a specific 
question. There is no specific benefit for you, if you take part in the study. However, 
taking part in the study may be of benefit to the community, as it may help us to 
understand the problem of defaulters and potential solutions.   
If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal 
medicine “Karisalankannichooranam” (Internal medicine) 800mg – 1000mg (B.D) for 
28 days.     
 
 
The information I am collecting in this study will remain between you and the 
Co- investigator (myself). I will ask you few questions through a questionnaire. I will 
not write your name on this form. I will use a code instead.   
The questionnaire will take approximately 20 minutes of your time.   
If you wish to find out more about this study before taking part, you can ask 
me all the questions you want or contact K. Karpagavalli, PG Scholar cum Co- 
investigator of this study, attached to Govt. Siddha Medical College, Chennai-106. 
You can also contact the Member-secretary of Ethics committee, Govt. Siddha 





அரசுசி த்த மருத்துவக் கல்லூரி , சென்னை-106 
அறி ஞர் அண்ணா  மருத்துவமனை, சென்னை 
பாண்டு நோய்க்கான சி த்த மருந்தி ன் (கரி சலங்கண்ணி  சூரணம்) பரி கரி ப்புத் 
தி றனைக் கண்டறி யும் மருத்துவ ஆய்வி ற்க்கான தகவல்படி வம் 
ஆராய்ச்சி யாளர் பெயர்: க.கற்பகவள்ளி  
நி றுவனத்தி ன் பெயர்: அரசு சி த்த மருத்துவக் கல்லூரி ,  
அரும்பாக்கம், சென்னை-106. 
 அரசு சி த்த மருத்துவக் கல்லூரி யி ல் பட்டமேற்படி ப்பு பயி ன்று வரும் நான் 
மருத்துவர் க. கற்பகவள்ளி  பாண்டு என்னு ம் நோயி ல் மருத்துவ ஆராய்ச்சி யி ல் 
ஈடுபட்டுள்ளேன். 
 இந்த நோய் உட்டச்சத்து குறைவி னா ல் ஏற்படுகி ன்றன. இதுபரவக் கூடி ய 
நோயல்ல.  
 இந்த ஆராய்ச்சி  சம்பந்தமாக சி ல கேள்வி களைக் கேட்கவும், தேவையான 
ஆய்வகப் பரி ச ோதனைக்கு தங்கள் குழந்தையை உட்படுத்தவும் உள்ளேன். 
 இந்த ஆராய்ச்சி க்கு தங்கள் வி ருப்பத்தி ன் பேரி ல் உட்படும் பட்சத்தி ல் 
உள்மருந்தாக கரி சலங்கண்ணி  சூரணம் 200மி .கி  – 500மி .கி  2 வேளை (காலை, 
மாலை) உணவுக்கு பி ன் 28 நாட்கள் உட்கொள்ள வேண்டும். வெளி  
நோயாளர்கள் 7 நாட்களு க்கு ஒருமுறை வரவேண்டும். 
 இந்த மருந்து சி றப்பாக பாண்டு நோய்க்காக அங்கீகரி க்கப்பட்ட 
சி த்தமருத்துவ நூலி ல் கூறப்பட்டுள்ளது . 
 இந்த ஆராய்ச்சி யி ல் தங்களை அனுமதி த்த பி றகு உங்களு க்கு வி ருப்பம் 
இல்லையெனி ல் எப்ப ோது வெண்டுமானாலு ம் ஆராய்ச்சி யி ல் இருந்து 
வி லகி க்க ொள்ள உரிமை உள்ளது . 
 இந்த ஆராய்ச்சி க்கு சம்பந்தமாக நோயி ன் தன்னை பற்றி யும் மற்ற 
வி பரங்களு க்கும் ஆராய்ச்சி யாளர் மருத்துவர் க.கற்பகவள்ளி  (பட்ட 
மேற்படி ப்பாளர், குழந்தை மருத்துவத்துறை) அவர்களை எந்த நேரத்தி லு ம் 
தொடர்பு கொள்ளலா ம். கைப்பேசி எண்: 7373127490. 
 
 
 மேலு ம் இந்த ஆராய்ச்சி க்கு தக்கஅனுமதி ச் சான்று பெறப்பட்டுள்ளது . 
 இந்த மருந்து மு ற்றி லு ம் பாதுகாப்பான மூலி கை ப ொருட்களைக் 
கொண்டு தயாரி க்கப்பட்டுள்ளது . பக்க வி ளைவுகளை ஏற்படுத்தாது . மேலு ம் 
உணவுமுறையி ல் மருத்துவரால் கூறப்படும் பத்தி யம்காக்குமாறு 
அறி வுறுத்தப்படுகி றது . 
 இது சம்பந்தமான தங்களது அனைத்து வி வரங்களு ம் ரகசி யமாக 
வைக்கப்படும் என உறுதி  அளி க்கி றேன். 
 இதி ல் பயணப்படி  முதலி ய எந்த உதவி த் தொகையும் 
வழங்கப்படமாட்டாது . 
 இந்த ஆராய்ச்சி யி ன் ப ோது உடலு க்கு வேறு பாதி ப்பு ஏற்படும் பட்சத்தி ல் 





GOVERNMENT SIDDHA MEDICAL COLLEGE ARIGNAR ANNA 
GOVERNMENT HOSPITAL OF INDIAN MEDICINE  
CHENNAI – 600 106  
CLINICAL STUDY ON “KARISALANKANNI CHOORANAM” IN THE 
TREATMENT OF “PAANDU NOI”  (IRON DEFICIENCY 
ANAEMIA)IN CHILDREN  
FORM X - ADVERSE REACTION REPORTING FORM 
 
SERIAL NO  :                                                                                                            
OP/IP NO  :  
NAME  :                                                      
AGE  :                 GENDER  :  
DATE OF TRIAL COMMENCEMENT :  
DATE OF OCCURRENCE OF THE ADVERSE REACTION :   
TIME  :  
DESCRIPTION OF ADVERSE REACTION :  
 
MANAGEMENT :  
 
Date :                                                                               
Station :  
 
 




DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
DISSERTATION STUDY ON “KARISALANKANNI CHOORANAM” 
IN PAANDU NOI (IRON DEFICIENCY ANAEMIA) 
INVESTIGATOR – Dr. K. KARPAGAVALLI 
ANNA HOSPITAL OPD- CHENNAI-106  
OP.NO  :                                                     DATE : 
NAME  :                                                                                      
AGE / SEX  :  
PARENT NAME :  
ADDRESS  :  
 
PHONE NO  :  
COMPLAINTS & DURATION 
 Loss of appetite  
 Fatigue   
 Worm infestation   
 Pallor of skin and mucous membrane  
 Lack of concentration  
ECONOMIC STATE   :          POOR / MIDDLE / RICH  
DIET       :          VEG / MIXED  
H/O PICA       :   
FAMILY HISTORY    :  
PAST HISTORY    :  
ON EXAMINATION 
HT     :    
WT     :                      
PALLOR   :  
CVS     :  




NAA  :       MALAM  :  
NIRAM  :      MOOTHIRAM : 
MOZHI  :         NAADI   :  
VIZHI   :         SPARISM   :  
 
INVESTIGATION: 
 BEFORE AFTER  BEFORE AFTER 
BLOOD   S. FERRITIN   
TC   TIBC   
DC   URINE   
ESR   Alb   
Hb   Sugar   
RBC   Deposit   
PCV   MOTION   
MCV   Ova   
MCH   Cyst   



















I.      
II.      
III.      
IV.      
V.      
 
 
GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
CHENNAI 
Branch -IV KUZHANTHAI MARUTHUVAM 
PROFORMA OF CASE SHEET FOR PAANDU NOI 
IP. No  :         Nationality   :  
Name    :         Religion   :  
Age     :         Date of Admission  :  
Sex     :         Date of Discharge  :  
Address     :          Diagnosis   :  
Informant   :         Medical Officer  :  
1. Complaints and duration :  
2. History of present illness    :  
3. History of Past illness    :  
4. Antenatal history     :  
5. Birth history      :  
6. Neonatal history      :  
7. Developmental  history    :  
8. Nutritional  history     :  
9. Immunization history    :  
10. Family history      :  
11. Socio economic status    :  
General examination:  
1. Appearance and posture    :  
2. Nutritional status      :  
3. Anaemia        :  
4. Cyanosis        :  
5. Clubbing        :  
6. Jaundice        :  
 
 
7. Lymphadenopathy      :     
8. Abdominal distension     :  
9. Pedal oedema       :  
Vital Signs:  
1. Temperature    :  
2. Pulse rate     :  
3. Respiratory rate   :  
4. Heart rate     :  
5. Blood pressure     :  
Anthropometry  
a. Height     :  
b. Weight     :  
c. Chest circumference  :  
SIDDHA ASPECTS   
Nilam 
1. Kurinji :  
2. Mullai :  
3. Marutham :  
4. Neithal :  
5. Paalai :  
Paruvakalam 
1. Kaar   :  
2. Koothir  :  
3. Munpani  :  
4. Pinpani  :  
5. Elavenil  :  





1. Mei     : 
2. Vai  :  
3. Kan  :  
4. Mooku  :  
5. Sevi  :  
Kanmenthiriyam 
1. Kai    :  
2. Kaal :  
3. Vaai :  
4. Eruvai :  
5. Karuvai :  
Uyirthathukkal 
Vadham 
1. Praanan :  
2. Abaanan :  
3. Viyaanan :  
4. Uthaanan :  
5. Samaanan :  
6. Naagan :  
7. Koorman :  
8. Kirukaran :  
9. Devathathan :  
10. Dhananjeyan :  
Pitham 
1. Analpitham :  
2. Ranjagam :  
3. Saadhagam :  
4. Praasagam :  




1. Avalambagam  :  
2. Kiletham :  
3. Pothagam :  
4. Tharpagam :  
5. Santhigam :  
UdalKattugal 
1. Saaram  :  
2. Senneer  :  
3. Oon   :  
4. Kozhuppu  :  
5. Enbu   :  
6. Moolai   :  
7. Sukkilam /Suronitham:    
EnvagaiThervugal 
1. Naadi  :  
2. Sparisam :  
3. Naa  :  
4. Niram  :  
5. Mozhi  :  
6. Vizhi  :  
7. Malam   :  
8. Moothiram :  
MODERN ASPECTS   
1. Respiratory System    :  
2. Cardiovascular system   :  
3. Gastro intestinal system  :  
4. Central nervous system  :  
5. Excretory system    :  




TC    :  
DC    :  
ESR    
1/2 hr   :  
1 hr   :  
Hb%   : 
Urine  
Albumin   :  
Sugar    :  
Deposits  :  
Stools  
Ova   :  
Cyst   :  
Other Investigations  
PCV :  
MCV :  





Investigation - Siddha aspect  
 1. Neerkuri 
Niram  :  
Edai  :  
Manam :  
Nurai  :  
Enjal  :  
2. Neikuri 
 
3. Daily progress 
DATE SYMPTOMS MEDICINE 
   
   
   
   
   
 






